{ "schemaVersion": "deck-intelligence.v1", "id": "019de072-7781-7512-96cc-a2b05ce755c7", "slug": "b1746432eb5f270eac90273cddb862aa", "title": "Bionomics | Investor Presentation Deck | 38 slides", "subtitle": "Bionomics · 2022-04", "author": "Bionomics", "date": "2022-04-01 00:00:00", "pageCount": 38, "kind": "pitchdeck", "orientation": "landscape", "aspectRatio": 1.7777778, "document": { "id": "019de072-7781-7512-96cc-a2b05ce755c7", "slug": "b1746432eb5f270eac90273cddb862aa", "title": "Bionomics | Investor Presentation Deck | 38 slides", "rawTitle": "Bionomics | Investor Presentation Deck | 38 slides", "authorId": "bionomics", "authorName": "Bionomics", "authorDisplay": "Bionomics", "kind": { "slug": "pitchdeck", "label": "Pitch deck" }, "sourceType": { "slug": "investor_relations", "label": "Investor relations" }, "fileName": "2022-04__bionomics__investor-pres__b1746432.pdf", "sourceUrl": "https://www.slidebook.io/company/bionomics/presentation/b1746432eb5f270eac90273cddb862aa/", "sourceDate": "2022-04-15 00:00:00", "presentationDate": "2022-04-01 00:00:00", "ingestedAt": "2026-04-30 22:11:31.431835+00", "status": "ready", "pageCount": 38, "orientation": "landscape", "aspectRatio": 1.7777778, "targetCompany": null, "targetTicker": null, "metadata": { "corpus": "slidebook", "industry": "biotechnology", "local_root": "/Users/miguelsuredasuau/Desktop/lalalalla/_scrape/slidebook/decks/2022-04__bionomics__investor-pres__b1746432", "image_width": 1920, "image_format": "jpg", "deck_type_raw": "Investor Presentation Deck", "deck_type_slug": null, "source_url_pattern": "https://www.slidebook.io/company/{company_slug}/presentation/{deck_id}/" } }, "coverage": { "pageCount": 38, "pagesIndexed": 38, "pagesWithImages": 38, "pagesWithMetadata": 38, "imageCoveragePct": 100, "metadataCoveragePct": 100, "componentCount": 183, "chartCount": 15, "metricSlides": 0, "toolMatches": 11, "documentToolMatches": 0, "frameworkMatches": 16, "arcMatches": 1, "beatMatches": 5, "loopMatches": 3, "patternMatches": 0, "storymakersMatch": false, "scoreAvailable": false, "reviewAvailable": false, "activistThesisAvailable": false, "pitchdeckMetadataAvailable": false, "pitchdeckProfileAvailable": false }, "blocks": [], "matches": { "arcs": [ { "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "matchId": "cd74960b-1c5d-48f9-8531-0845487ffab4", "evidence": "The deck follows a structure similar to the Sequoia Pitch, with sections on problem, solution, market sizing, traction, and investment highlights.", "isPrimary": true, "confidence": 0.8, "extraction": { "at": "2026-07-16 22:20:55.476988+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "beats": [ { "to": 15, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "from": 15, "name": "Problem", "beatId": "b1c78737-9b27-4aeb-b978-208a1cc9d0d6", "matchId": "cd74960b-1c5d-48f9-8531-0845487ffab4", "beatType": { "name": "Problem", "slug": "sequoia-pitch-problem", "status": "active", "canonId": "019dd9b8-1ed4-767b-8e05-40e733bd2311", "version": 1, "description": null }, "evidence": "The problem statement is presented on page 15, highlighting the disease burden of Post-Traumatic Stress Disorder.", "position": 0, "isPrimaryArc": true, "parentBeatType": { "name": "Complication", "slug": "complication", "status": "active", "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579", "version": 1, "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs." }, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 6, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "from": 5, "name": "Solution", "beatId": "6ae55fc5-268b-41d1-893d-88fd5f9a266e", "matchId": "cd74960b-1c5d-48f9-8531-0845487ffab4", "beatType": { "name": "Solution", "slug": "sequoia-pitch-solution", "status": "active", "canonId": "019dd9b8-1fb1-71d9-a260-07738d7f9c2f", "version": 1, "description": null }, "evidence": "The solution is presented on pages 5-6, introducing Bionomics' differentiated approach through the α7 Nicotinic Acetylcholine Receptor.", "position": 1, "isPrimaryArc": true, "parentBeatType": { "name": "Turn", "slug": "turn", "status": "active", "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54", "version": 1, "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat." }, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 8, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "from": 8, "name": "Market Size", "beatId": "33329ff7-078b-49a3-8d13-511e2664c27b", "matchId": "cd74960b-1c5d-48f9-8531-0845487ffab4", "beatType": { "name": "Market Size", "slug": "sequoia-pitch-market-size", "status": "active", "canonId": "019dd9b8-20e6-729c-bc28-05442906d032", "version": 1, "description": null }, "evidence": "Market sizing is presented on page 8, targeting a large segment of the anxiety market.", "position": 2, "isPrimaryArc": true, "parentBeatType": { "name": "Evidence", "slug": "evidence", "status": "active", "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a", "version": 1, "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development." }, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 10, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "from": 9, "name": "Traction", "beatId": "50748b04-b9b4-4fc9-8bc4-af166cf1058b", "matchId": "cd74960b-1c5d-48f9-8531-0845487ffab4", "beatType": null, "evidence": "Traction is presented on pages 9-10, showcasing BNC210's efficacy in reducing panic symptoms and demonstrating acute anxiolytic activity.", "position": 3, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 12, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null, "categoryName": "Strategy & Business", "categorySlug": "strategy-business" }, "from": 12, "name": "Why Now", "beatId": "5a730e5a-abd5-4b84-8096-b3f5be8f655b", "matchId": "cd74960b-1c5d-48f9-8531-0845487ffab4", "beatType": { "name": "Why Now", "slug": "sequoia-pitch-why-now", "status": "active", "canonId": "019dd9b8-204f-77ee-82c8-8ebaf0870ff9", "version": 1, "description": null }, "evidence": "The why now section is presented on page 12, highlighting BNC210's rapid onset of action and its potential in Social Anxiety Disorder.", "position": 4, "isPrimaryArc": true, "parentBeatType": { "name": "Evidence", "slug": "evidence", "status": "active", "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a", "version": 1, "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 3, "from": 3, "loop": { "name": "11_golden_circle", "slug": "11-golden-circle", "status": "active", "bestFor": "Visionary leadership, brand positioning, mission statements", "canonId": "019dd956-6a50-7202-882d-505fcb9922ed", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "description": "Invert the typical pitch by starting with why you exist, rather than what you do", "familyLabel": null, "categoryName": "Vision", "categorySlug": "vision" }, "matchId": "534850f6-e55a-4574-9629-3b850bee51af", "evidence": "The executive summary on page 3 presents an overview of Bionomics as an emerging leader in neuropsychiatry.", "position": 0, "objective": "Why Bionomics?", "confidence": 0.7, "extraction": { "at": "2026-07-16 22:20:55.677908+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } }, { "to": 15, "from": 15, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null, "categoryName": "Urgency", "categorySlug": "urgency" }, "matchId": "53e8a626-52c3-439a-8010-21e4ca9d800f", "evidence": "The problem statement on page 15 highlights the disease burden of PTSD.", "position": 1, "objective": "What is the cost of not treating PTSD effectively?", "confidence": 0.6, "extraction": { "at": "2026-07-16 22:20:55.710708+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } }, { "to": 10, "from": 9, "loop": { "name": "47_quick_win_big_bet", "slug": "47-quick-win-big-bet", "status": "active", "bestFor": "Transformation planning, 100-day plans, resource allocation", "canonId": "019dd956-790d-708d-983e-ef9bbc68f741", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "description": "Separate initiatives into immediate wins and longer-term strategic bets", "familyLabel": null, "categoryName": "Consulting Framework", "categorySlug": "consulting-framework" }, "matchId": "5449b11f-140a-484b-a6d0-f26616247fcf", "evidence": "The traction section on pages 9-10 presents BNC210's efficacy in reducing panic symptoms and demonstrating acute anxiolytic activity.", "position": 2, "objective": "Can BNC210 provide a quick win in treating anxiety disorders?", "confidence": 0.6, "extraction": { "at": "2026-07-16 22:20:55.74398+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "tools": [ { "tool": { "name": "Executive summary", "slug": "executive-summary", "status": "active", "bestFor": null, "canonId": "019dd9e1-4b63-72d5-9734-da757d91ca61", "version": 1, "bodyDocId": null, "description": "A condensed view of the entire argument on a single slide / block.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "a93c3b4a-8aa1-46cb-8ee6-bcf26794f971", "evidence": "This slide is titled 'Emerging Leader in Neuropsychiatry' and contains a list of bullet points summarizing the company's overview.", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-16 23:58:10.470805+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 3, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null }, { "tool": { "name": "2x2 matrix", "slug": "matrix-2x2", "status": "active", "bestFor": null, "canonId": "019dd9e1-50ab-72d1-8afb-3ab0a38e32a8", "version": 1, "bodyDocId": null, "description": "BCG matrix, importance/urgency, any axes-and-quadrants frame.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "7c453584-0c63-4614-84cc-fe7edd4a50f2", "evidence": "table/data: Comparison table of Benzodiazepines and SSRIs/SNRIs against 5 criteria, table/data: Comparison table of BNC210 against 5 criteria", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-16 23:58:23.629409+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 11, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null }, { "tool": { "name": "Flywheel", "slug": "flywheel", "status": "active", "bestFor": null, "canonId": "019de52d-1ad8-75ab-9027-a40365590152", "version": 1, "bodyDocId": null, "description": null, "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "57119e88-dcff-4e27-96f0-e7fc20aaa70a", "evidence": "diagram/hub-spoke: Flywheel showing BNC210 benefits: Novel Mechanism, Attractive Pathway, Rapid Onset, Unique Formulation, Anti-Anxiety Effects", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-16 23:58:23.586721+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 11, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null }, { "tool": { "name": "List presentation", "slug": "list-presentation", "status": "active", "bestFor": null, "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1", "version": 1, "bodyDocId": null, "description": "Bulleted, numbered, or checklist enumerations.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "526cdb64-5721-4dd6-8960-cf5197ca0acc", "evidence": "list/bullet: Rapid Onset of Action with BNC210 Formulation: Clinically demonstrated potential for reducing anxiety; Observed acute anxiolytic efficacy similar to lorazepam; Formulation well-suited for acute dosing.", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.8, "extraction": { "at": "2026-07-16 23:58:23.715669+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 12, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null }, { "tool": { "name": "List presentation", "slug": "list-presentation", "status": "active", "bestFor": null, "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1", "version": 1, "bodyDocId": null, "description": "Bulleted, numbered, or checklist enumerations.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "6fe6a58b-7aba-4e49-a259-f98d2f76b629", "evidence": "list/bullet: 70% of people will experience a traumatic event in their lifetime, but most people recover normally; PTSD results from exposure to actual or threatened death, serious injury or sexual violence; Affects up to", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.8, "extraction": { "at": "2026-07-16 23:58:23.885942+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 15, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null }, { "tool": { "name": "Vertical Logic", "slug": "vertical-logic", "status": "active", "bestFor": null, "canonId": "019dd956-9a25-77b9-9302-04662b84c32b", "version": 1, "bodyDocId": null, "description": "Question/Answer flow down the hierarchy - each level answers Why? or How?", "familyLabel": null, "categoryName": "Loop", "categorySlug": "loop" }, "agent": "Architect", "layer": "slide", "agents": [ "Architect" ], "matchId": "99c14a9b-324f-46f4-808a-d9d7efb5f174", "evidence": "framework/instance: Vertical timeline of strategic milestones", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-16 23:58:17.089797+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 25, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null }, { "tool": { "name": "Table data", "slug": "table-data", "status": "active", "bestFor": null, "canonId": "019dd9e1-4fab-7168-a82f-b847350a006d", "version": 1, "bodyDocId": null, "description": "Tabular layouts of structured data.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "957c02cb-3d67-46b2-b5d5-02eac9403229", "evidence": "table/data: Clinical trial data table with columns: Phase, Description, Participants/Setting, Subjects Enrolled, Formulation/Doses, Location", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-16 23:58:17.333184+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 30, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null }, { "tool": { "name": "Table data", "slug": "table-data", "status": "active", "bestFor": null, "canonId": "019dd9e1-4fab-7168-a82f-b847350a006d", "version": 1, "bodyDocId": null, "description": "Tabular layouts of structured data.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "ae7f4df9-bb04-47cd-b7bd-ac7389daf463", "evidence": "table/data: Study Design: Multi-center, randomized, double-blind, placebo-controlled; BNC210 150 mg, 300 mg, 600 mg and placebo (1:1:1:1); 12-week treatment period; 193 participants; 20 US sites / 6 Australian sites. Key", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-16 23:58:17.455792+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 32, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null }, { "tool": { "name": "AIDA Model", "slug": "aida-model", "status": "active", "bestFor": null, "canonId": "019dd956-86fc-773c-813f-d416714b8413", "version": 1, "bodyDocId": null, "description": "Attention, Interest, Desire, Action - classic persuasion sequence", "familyLabel": null, "categoryName": "Block", "categorySlug": "block" }, "agent": "Storyteller", "layer": "slide", "agents": [ "Storyteller" ], "matchId": "162cc8d1-ffea-490c-8cc7-ae7ad046d967", "evidence": "The slide presents a clear attention-grabbing headline, followed by a brief description of the therapeutic strategy, and supporting evidence from a lead compound, which aligns with the AIDA model's structure of Attention, Interest, Desire, and Action.", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-16 23:58:06.446073+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 35, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null }, { "tool": { "name": "AIDA Model", "slug": "aida-model", "status": "active", "bestFor": null, "canonId": "019dd956-86fc-773c-813f-d416714b8413", "version": 1, "bodyDocId": null, "description": "Attention, Interest, Desire, Action - classic persuasion sequence", "familyLabel": null, "categoryName": "Block", "categorySlug": "block" }, "agent": "Storyteller", "layer": "slide", "agents": [ "Storyteller" ], "matchId": "0c1dda3e-d919-4362-9883-96255a60200e", "evidence": "Similar to slide 1, this slide presents a clear attention-grabbing headline, followed by a brief description of the therapeutic strategy, and supporting evidence from a lead compound, which aligns with the AIDA model's structure.", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-16 23:58:06.514195+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 36, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null }, { "tool": { "name": "Before-After-Bridge", "slug": "before-after-bridge", "status": "active", "bestFor": null, "canonId": "019dd956-8604-7188-883f-42370288ad05", "version": 1, "bodyDocId": null, "description": "Narrative structure: Paint the before, show the after, explain the bridge", "familyLabel": null, "categoryName": "Block", "categorySlug": "block" }, "agent": "Storyteller", "layer": "slide", "agents": [ "Storyteller" ], "matchId": "8a923516-f8ab-4e4f-9ab4-e73f2d61e488", "evidence": "The slide presents a clear 'before' state (legacy oncology assets) and an 'after' state (monetization of these assets through a licensing agreement), which aligns with the before-after-bridge tool.", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.8, "extraction": { "at": "2026-07-16 23:58:06.623546+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 38, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [ { "matchId": "81e8de65-64c0-4f8c-8f98-ef1433726444", "evidence": "Vertical list of company highlights", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 12:57:44.384+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 3, "frameworkName": "list-presentation" }, { "matchId": "4863e95b-10c5-44eb-aca9-837b483a1a29", "evidence": "The slide uses a horizontal bar structure to represent clinical trial progress over time.", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 12:57:43.971+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 4, "frameworkName": "gantt-chart" }, { "matchId": "25fdbe87-3867-4d57-8ab4-0ad00d04fad5", "evidence": "The slide uses a numbered sequence (1-4) to explain the biological mechanism of action.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 12:57:44.578+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 5, "frameworkName": "process" }, { "matchId": "6c4c9655-8b23-4862-a71d-c71aed55cf6c", "evidence": "Visual representation of biological pathway and therapeutic intervention", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 12:57:45.01+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 6, "frameworkName": "mechanism-of-action" }, { "matchId": "7634036c-d8b1-4159-a7cf-1e089de6cc17", "evidence": "The funnel chart visualizes the narrowing of the total addressable market.", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 12:57:44.57+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 8, "frameworkName": "market-segmentation-pyramid" }, { "matchId": "a3c49f27-a548-4770-83fc-77c69a87cab8", "evidence": "Table comparing BNC210 to existing treatments", "framework": null, "confidence": 1, "extraction": { "at": "2026-05-02 12:57:45.632+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 11, "frameworkName": "comparison_table" }, { "matchId": "e360b125-92ae-4181-b1fe-10cd587a6e30", "evidence": "Circular diagram showing interconnected benefits of BNC210", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 12:57:45.632+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 11, "frameworkName": "flywheel" }, { "matchId": "fd6681cb-4c82-4f2c-b463-2de1f098f73a", "evidence": "Clinical trial design flow", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 12:57:46.139+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 13, "frameworkName": "process" }, { "matchId": "7fa5b35c-e1bc-406a-81f8-cdc231b9bd3f", "evidence": "The slide contrasts the problem (left callout) with the experimental results (charts) and the resulting benefits (bottom arrows).", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 12:57:46.33+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 16, "frameworkName": "before-after-bridge" }, { "matchId": "600c2aa8-7609-46bc-a079-1f83e569e8f2", "evidence": "Sequential flow of development stages", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 12:57:49.667+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 17, "frameworkName": "process" }, { "matchId": "0240f094-0ea3-4d4f-88ac-1383d276ddca", "evidence": "Timeline visualization of clinical trial phases", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 12:57:48.018+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 19, "frameworkName": "gantt-chart" }, { "matchId": "b31b990f-66e8-4ba7-b8a8-bc51d5b0b3b2", "evidence": "Vertical sequence of events and milestones", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 12:57:51.323+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 25, "frameworkName": "timeline" }, { "matchId": "d7afe2ae-2b69-4fdf-89a4-534003d36f90", "evidence": "Central hub with four surrounding quadrants representing symptom domains", "framework": null, "confidence": 1, "extraction": { "at": "2026-05-02 12:57:48.238+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 29, "frameworkName": "hub-spoke" }, { "matchId": "4145331a-c7e8-4554-81ba-67247acbd918", "evidence": "The process diagram links receptor activation to drug dosing and observed EEG reduction.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 12:57:48.219+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 31, "frameworkName": "causal-chain" }, { "matchId": "c64663e8-018a-4c0b-871d-c12b39de8b18", "evidence": "Structured presentation of study design, criteria, and objectives.", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 12:57:49.746+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 32, "frameworkName": "clinical-trial-design" }, { "matchId": "f670b55e-16ee-457c-b7b5-2f716b631c80", "evidence": "The top row uses chevron shapes to indicate a logical progression from genetics to clinical relevance.", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 12:57:48.15+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 36, "frameworkName": "process" } ], "patterns": [] }, "storymakers": null, "score": null, "review": null, "activistThesis": null, "pitchdeck": { "metadata": null, "profile": null }, "slides": [ { "page": 1, "type": "setup", "title": "Includes ticker symbols and date.", "function": "front_matter", "imagePath": "https://imgproxy.kitesheet.com/ZXquLYDEijPC64ZbK2PlHzca8-YYANrmi5229fQv_mM/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iMTc0NjQzMmViNWYyNzBlYWM5MDI3M2NkZGI4NjJhYS9wMDAxLmpwZw", "rawType": "cover", "block": null, "metadata": { "slideType": "cover", "slideTypeCanon": { "name": "Cover", "slug": "cover", "status": "active", "canonId": "019de52d-05f2-729d-9f93-e0504f0a2410", "version": 1, "description": null }, "function": "front_matter", "functionCanon": { "name": "Front matter", "slug": "front_matter", "status": "active", "canonId": "019de52d-133d-73f0-9e26-201eda96b098", "version": 1, "description": null }, "density": "balanced", "densityScore": 40, "componentCount": 6, "textChars": 147, "nDataPoints": 0, "notes": "Includes ticker symbols and date.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:43.13+00", "seconds": 2.474, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/1", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-1", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.84, "w": 0.42, "x": 0.52, "y": 0.08 }, "kind": "image", "text": "Brain circuit graphic", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Illustration", "slug": "illustration", "status": "active", "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615", "version": 1, "description": null }, "framework": null }, "subkind": "illustration", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:43.13+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "7c3000c7-79ce-44ad-b268-a00ec3ee45c6", "parentComponentId": null }, { "bbox": { "h": 0.172, "w": 0.172, "x": 0.808, "y": 0.781 }, "kind": "image", "text": "Bionomics logo", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:43.13+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "e7f27c6f-d66a-408a-994b-a7b14d55af32", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.1, "x": 0.07, "y": 0.78 }, "kind": "paragraph", "text": "April 2022", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:43.13+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0d84feb5-5d0a-47ee-9fe9-a4057b9837d3", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.1, "x": 0.07, "y": 0.64 }, "kind": "paragraph", "text": "ASX: BNO\nNasdaq: BNOX", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:43.13+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "45be7f32-dd78-480b-bda6-2d5e7d292f2b", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.2, "x": 0.07, "y": 0.54 }, "kind": "paragraph", "text": "Corporate Presentation", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:43.13+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8fe1dde3-96b6-4e8b-8ba4-6665ac8c5704", "parentComponentId": null }, { "bbox": { "h": 0.45, "w": 0.45, "x": 0.07, "y": 0.11 }, "kind": "title", "text": "TO IMPROVE THE LIVES OF PATIENTS WITH SERIOUS CNS DISORDERS", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:43.13+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "50d76da7-e8c0-4e90-be87-60ffc63fe5d8", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "thumbSrc": "https://imgproxy.kitesheet.com/z5rgVctocYDMOPiXkl1xXze8YIc6ceearA5cJtj0ugk/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iMTc0NjQzMmViNWYyNzBlYWM5MDI3M2NkZGI4NjJhYS9wMDAxLmpwZw", "imagePathAlt": "https://imgproxy.kitesheet.com/i_fkGZrnnYBgRCi94sE4pZoi5cnDrP1lnqIhQN8CnKw/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iMTc0NjQzMmViNWYyNzBlYWM5MDI3M2NkZGI4NjJhYS9wMDAxLnBuZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/6Uf-nPveLwDz8PFRAOKxnR81SeSDBlcqdaqNja_wvIY/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iMTc0NjQzMmViNWYyNzBlYWM5MDI3M2NkZGI4NjJhYS9wMDAxLnBuZw" }, { "page": 2, "type": "setup", "function": "other", "rawType": "disclaimer", "block": null, "metadata": { "slideType": "disclaimer", "slideTypeCanon": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "019de52d-0801-727b-b98a-5ed095aeee78", "version": 1, "description": null }, "function": "other", "functionCanon": { "name": "Other (fallback)", "slug": "other", "status": "active", "canonId": "019de52d-15e1-75bc-99dc-07732380e2ce", "version": 1, "description": null }, "density": "balanced", "densityScore": 28, "componentCount": 4, "textChars": 217, "nDataPoints": 0, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:43.428+00", "seconds": 2.615, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/2", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-2", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.689, "w": 0.933, "x": 0.033, "y": 0.167 }, "kind": "disclaimer", "text": "This presentation may contain \"forward-looking\" statements within the meaning of the United States' Private Securities Litigation Reform Act of 1995...", "attrs": null, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:43.428+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "37904700-e04f-481a-8707-4ce1f42ff1a1", "parentComponentId": null }, { "bbox": { "h": 0.078, "w": 0.95, "x": 0.025, "y": 0.889 }, "kind": "image", "text": "Bionomics", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:43.428+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8c552055-38b3-4fa2-8d75-b82e59f1134e", "parentComponentId": null }, { "bbox": { "h": 0.022, "w": 0.25, "x": 0.033, "y": 0.117 }, "kind": "paragraph", "text": "Factors Affecting Future Performance", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:43.428+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "23855503-9d42-45e4-a9a3-47c02cb0df03", "parentComponentId": null }, { "bbox": { "h": 0.033, "w": 0.278, "x": 0.033, "y": 0.044 }, "kind": "title", "text": "SAFE HARBOR STATEMENT", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:43.428+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4ef6a459-f3b2-4059-ac45-23999c0c8557", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 3, "type": "setup", "title": "Uses a vertical timeline-style list to present company highlights.", "function": "summarize", "rawType": "executive_summary", "block": null, "metadata": { "slideType": "executive_summary", "slideTypeCanon": { "name": "Executive summary", "slug": "executive_summary", "status": "active", "canonId": "019de52d-06be-73ff-81b3-f99fe7f0025e", "version": 1, "description": null }, "function": "summarize", "functionCanon": { "name": "Summarize", "slug": "summarize", "status": "active", "canonId": "019de52d-1541-704f-b86f-bf7b75056373", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 88, "componentCount": 9, "textChars": 1114, "nDataPoints": 1, "notes": "Uses a vertical timeline-style list to present company highlights.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:44.384+00", "seconds": 3.547, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/3", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-3", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.08, "w": 0.77, "x": 0.17, "y": 0.14 }, "kind": "list", "text": "Diversified, clinical-stage biopharmaceutical company developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious Central Nervous System (CNS) disorders", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:44.384+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4da3450a-9621-4a6b-8376-3d4c4aef102d", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.77, "x": 0.17, "y": 0.25 }, "kind": "list", "text": "BNC210 in Phase 2 for acute treatment in Social Anxiety Disorder (SAD) – Established clinical PoC in GAD and Fast Track designation from FDA for SAD", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:44.384+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "63189f20-b735-482b-9f25-95d10e60213f", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.77, "x": 0.17, "y": 0.76 }, "kind": "list", "text": "Well-capitalized balance sheet with multiple potential near term value-driving milestones", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:44.384+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "64d4a2c0-6d37-46d7-b968-3435e040692a", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.77, "x": 0.17, "y": 0.35 }, "kind": "list", "text": "BNC210 in ongoing Phase 2b ATTUNE trial with Fast Track designation from FDA for PTSD", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:44.384+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8482f2fe-208a-45f6-a863-d11e30017a38", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.77, "x": 0.17, "y": 0.66 }, "kind": "list", "text": "Pipeline of partnering candidates targeting potassium (Kv) and sodium (Nav) ion channels", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:44.384+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "86ec1983-87ec-4871-8bc0-ae4983f75128", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.77, "x": 0.17, "y": 0.56 }, "kind": "list", "text": "Strategic partnership with Merck & Co. for cognitive impairment in Alzheimer’s disease and other CNS conditions", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:44.384+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "b4c22303-cde1-4e65-bcf0-7bb978373868", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.77, "x": 0.17, "y": 0.45 }, "kind": "list", "text": "Large underserved markets with over 22 million patients in the United States alone suffering from SAD and PTSD and no new FDA approved therapies in nearly two decades", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:44.384+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "df34aa47-6e3a-4244-a024-00422f11cab1", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.45, "x": 0.14, "y": 0.87 }, "kind": "source-note", "text": "PoC = Proof of Concept; GAD = Generalized Anxiety Disorder; PTSD = Post-Traumatic Stress Disorder; 1. Wise et al 2020, Biological Psychiatry; Perkins et al 2021, Molecular Psychiatry", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:44.384+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "9454126a-3498-4979-96e6-9496e93d7a9a", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.35, "x": 0.08, "y": 0.04 }, "kind": "title", "text": "Emerging Leader in Neuropsychiatry", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:44.384+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "1365ce58-129d-41cb-a1cc-dca028f612c8", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "Executive summary", "slug": "executive-summary", "status": "active", "bestFor": null, "canonId": "019dd9e1-4b63-72d5-9734-da757d91ca61", "version": 1, "bodyDocId": null, "description": "A condensed view of the entire argument on a single slide / block.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "a93c3b4a-8aa1-46cb-8ee6-bcf26794f971", "evidence": "This slide is titled 'Emerging Leader in Neuropsychiatry' and contains a list of bullet points summarizing the company's overview.", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-16 23:58:10.470805+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 3, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null } ], "frameworks": [ { "matchId": "81e8de65-64c0-4f8c-8f98-ef1433726444", "evidence": "Vertical list of company highlights", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 12:57:44.384+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 3, "frameworkName": "list-presentation" } ], "arcBeats": [], "loops": [ { "to": 3, "from": 3, "loop": { "name": "11_golden_circle", "slug": "11-golden-circle", "status": "active", "bestFor": "Visionary leadership, brand positioning, mission statements", "canonId": "019dd956-6a50-7202-882d-505fcb9922ed", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "description": "Invert the typical pitch by starting with why you exist, rather than what you do", "familyLabel": null }, "matchId": "534850f6-e55a-4574-9629-3b850bee51af", "evidence": "The executive summary on page 3 presents an overview of Bionomics as an emerging leader in neuropsychiatry.", "position": 0, "objective": "Why Bionomics?", "confidence": 0.7, "extraction": { "at": "2026-07-16 22:20:55.677908+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 4, "type": "resolution", "title": "The slide uses a standard pharmaceutical pipeline table format.", "function": "plan_implementation", "rawType": "roadmap", "block": null, "metadata": { "slideType": "roadmap", "slideTypeCanon": { "name": "Roadmap", "slug": "roadmap", "status": "active", "canonId": "019de52d-0a55-72bc-9b7b-a47ef109839c", "version": 1, "description": null }, "function": "plan_implementation", "functionCanon": { "name": "Plan implementation", "slug": "plan_implementation", "status": "active", "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823", "version": 1, "description": null }, "density": "balanced", "densityScore": 26, "componentCount": 3, "textChars": 201, "nDataPoints": 4, "notes": "The slide uses a standard pharmaceutical pipeline table format.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:43.971+00", "seconds": 2.863, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/4", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-4", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.04, "w": 0.25, "x": 0.13, "y": 0.87 }, "kind": "disclaimer", "text": "NAM = Negative Allosteric Modulator; PAM = Positive Allosteric Modulator", "attrs": null, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:43.971+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "fcfb4ae3-a53c-43ac-9cdc-cddab56caafe", "parentComponentId": null }, { "bbox": { "h": 0.75, "w": 0.88, "x": 0.06, "y": 0.13 }, "kind": "table", "text": "Pipeline table showing programs, clinical phases, and timing", "attrs": null, "canon": { "kind": { "name": "Table", "slug": "table", "status": "active", "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28", "version": 1, "description": "Tabular data layout." }, "tool": null, "subkind": { "name": "Data table", "slug": "data", "status": "active", "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569", "version": 1, "description": null }, "framework": null }, "subkind": "data", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:43.971+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "91a48aa2-836f-49de-9568-2ff0cd73ce54", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.65, "x": 0.07, "y": 0.03 }, "kind": "title", "text": "Focused CNS Pipeline with Multiple Potential Catalysts on the Horizon", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:43.971+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "db1aa87d-c2c5-4150-a6a4-51b7f588b784", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "4863e95b-10c5-44eb-aca9-837b483a1a29", "evidence": "The slide uses a horizontal bar structure to represent clinical trial progress over time.", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 12:57:43.971+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 4, "frameworkName": "gantt-chart" } ], "arcBeats": [], "loops": [], "locked": true }, { "page": 5, "type": "resolution", "title": "The slide uses a biological process diagram to explain allosteric modulation and a conceptual graph to illustrate how NAMs and PAMs restore normal activity.", "function": "present_solution", "rawType": "solution", "block": null, "metadata": { "slideType": "solution", "slideTypeCanon": { "name": "Solution", "slug": "solution", "status": "active", "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282", "version": 1, "description": null }, "function": "present_solution", "functionCanon": { "name": "Present solution", "slug": "present_solution", "status": "active", "canonId": "019de52d-15b8-71da-bd23-2b767850cbce", "version": 1, "description": null }, "density": "balanced", "densityScore": 48, "componentCount": 4, "textChars": 652, "nDataPoints": 0, "notes": "The slide uses a biological process diagram to explain allosteric modulation and a conceptual graph to illustrate how NAMs and PAMs restore normal activity.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:44.578+00", "seconds": 3.41, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/5", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-5", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.7, "w": 0.45, "x": 0.52, "y": 0.15 }, "kind": "chart", "text": "Conceptual graph showing hypercholinergic and hypocholinergic disease states relative to normal activity.", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Line chart", "slug": "line", "status": "active", "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677", "version": 1, "description": null }, "framework": null }, "subkind": "line", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:44.578+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f5a613b8-0180-4705-8486-ddb7d2d6b065", "parentComponentId": null }, { "bbox": { "h": 0.7, "w": 0.45, "x": 0.03, "y": 0.15 }, "kind": "diagram", "text": "Mechanism of action showing ACh binding, Ca2+ flow, and allosteric drug binding in the transmembrane domain.", "attrs": null, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": { "name": "Process flow", "slug": "process", "status": "active", "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838", "version": 1, "description": null }, "framework": null }, "subkind": "process", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:44.578+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "fcf9bce5-8abc-4a87-a386-ec414f5bb090", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.45, "x": 0.13, "y": 0.88 }, "kind": "paragraph", "text": "Ca2+ = Calcium ions; ACh = Acetylcholine; NAM = Negative Allosteric Modulator; PAM = Positive Allosteric Modulator; Cholinergic = System associated with memory, selective attention, and emotional processing cognitive functions; PTSD = Post-Traumatic Stress Disorder; CIAS = Cognitive Impairment Associated with Schizophrenia; ADHD = Attention Deficit Hyperactivity Disorder", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:44.578+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "b72fc14c-f07e-4e5b-ac2f-d4717bfa6976", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.65, "x": 0.07, "y": 0.03 }, "kind": "title", "text": "A Differentiated Approach: The α7 Nicotinic Acetylcholine Receptor", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:44.578+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "1aee6f63-467c-4936-885a-398280266bb6", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "25fdbe87-3867-4d57-8ab4-0ad00d04fad5", "evidence": "The slide uses a numbered sequence (1-4) to explain the biological mechanism of action.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 12:57:44.578+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 5, "frameworkName": "process" } ], "arcBeats": [ { "to": 6, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null }, "from": 5, "name": "Solution", "beatId": "6ae55fc5-268b-41d1-893d-88fd5f9a266e", "matchId": "cd74960b-1c5d-48f9-8531-0845487ffab4", "beatType": { "name": "Solution", "slug": "sequoia-pitch-solution", "status": "active", "canonId": "019dd9b8-1fb1-71d9-a260-07738d7f9c2f", "version": 1, "description": null }, "evidence": "The solution is presented on pages 5-6, introducing Bionomics' differentiated approach through the α7 Nicotinic Acetylcholine Receptor.", "position": 1, "isPrimaryArc": true, "parentBeatType": { "name": "Turn", "slug": "turn", "status": "active", "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54", "version": 1, "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true }, { "page": 6, "type": "resolution", "title": "Uses a biological mechanism diagram to contrast normal vs. disease states and the therapeutic intervention.", "function": "present_solution", "rawType": "solution", "block": null, "metadata": { "slideType": "solution", "slideTypeCanon": { "name": "Solution", "slug": "solution", "status": "active", "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282", "version": 1, "description": null }, "function": "present_solution", "functionCanon": { "name": "Present solution", "slug": "present_solution", "status": "active", "canonId": "019de52d-15b8-71da-bd23-2b767850cbce", "version": 1, "description": null }, "density": "dense", "densityScore": 62, "componentCount": 6, "textChars": 558, "nDataPoints": 0, "notes": "Uses a biological mechanism diagram to contrast normal vs. disease states and the therapeutic intervention.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:45.01+00", "seconds": 3.75, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/6", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-6", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.63, "w": 0.22, "x": 0.024, "y": 0.168 }, "kind": "callout", "text": "Action of BNC210 depends on Acetylcholine neurotransmission and Allosteric Modulation of a7 nAChR", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": null, "subkind": { "name": "Primary callout", "slug": "primary", "status": "active", "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d", "version": 1, "description": null }, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.01+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "83da5210-c05e-4803-a739-9c09db55bcb0", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.25, "x": 0.136, "y": 0.875 }, "kind": "disclaimer", "text": "nAChR = Nicotinic Acetylcholine Receptor; NAM = Negative Allosteric Modulator; Ca2+ = Calcium ions; ACh = Acetylcholine", "attrs": null, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.01+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "bcd3f260-0dfe-40f6-9aa0-f993730258e6", "parentComponentId": null }, { "bbox": { "h": 0.65, "w": 0.58, "x": 0.345, "y": 0.108 }, "kind": "image", "text": "Diagram showing brain regions and receptor-level mechanism for Normal vs Anxiety/PTSD states", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Illustration", "slug": "illustration", "status": "active", "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615", "version": 1, "description": null }, "framework": null }, "subkind": "illustration", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.01+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "43340a3f-c892-4ba8-b484-a09ad7c1eff4", "parentComponentId": null }, { "bbox": { "h": 0.12, "w": 0.08, "x": 0.29, "y": 0.58 }, "kind": "legend", "text": "ACh, Ca2+, BNC210 legend", "attrs": null, "canon": { "kind": { "name": "Legend", "slug": "legend", "status": "active", "canonId": "31361933-3d22-4c70-bbad-0801e9fffc0c", "version": 1, "description": "Color/symbol decoder placed adjacent to a chart or diagram." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.01+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a6097fd6-ee71-436c-b48a-ad8e9e5f7f1a", "parentComponentId": null }, { "bbox": { "h": 0.12, "w": 0.75, "x": 0.218, "y": 0.765 }, "kind": "paragraph", "text": "NAMs have self-limiting activity determined by the cooperative interaction between BNC210 and Acetylcholine binding at the allosteric and orthosteric sites, respectively", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.01+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c6dffc62-7c4f-4ab2-9dc0-1e509b1e1151", "parentComponentId": null }, { "bbox": { "h": 0.035, "w": 0.628, "x": 0.076, "y": 0.035 }, "kind": "title", "text": "Harnessing the Power of a Novel Neuromodulatory Mechanism", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.01+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "87ed5a53-b141-409c-a157-270fee9c050d", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "6c4c9655-8b23-4862-a71d-c71aed55cf6c", "evidence": "Visual representation of biological pathway and therapeutic intervention", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 12:57:45.01+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 6, "frameworkName": "mechanism-of-action" } ], "arcBeats": [ { "to": 6, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null }, "from": 5, "name": "Solution", "beatId": "6ae55fc5-268b-41d1-893d-88fd5f9a266e", "matchId": "cd74960b-1c5d-48f9-8531-0845487ffab4", "beatType": { "name": "Solution", "slug": "sequoia-pitch-solution", "status": "active", "canonId": "019dd9b8-1fb1-71d9-a260-07738d7f9c2f", "version": 1, "description": null }, "evidence": "The solution is presented on pages 5-6, introducing Bionomics' differentiated approach through the α7 Nicotinic Acetylcholine Receptor.", "position": 1, "isPrimaryArc": true, "parentBeatType": { "name": "Turn", "slug": "turn", "status": "active", "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54", "version": 1, "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true }, { "page": 7, "type": "setup", "function": "transition", "rawType": "section_divider", "block": null, "metadata": { "slideType": "section_divider", "slideTypeCanon": { "name": "Section divider", "slug": "section_divider", "status": "active", "canonId": "019de52d-066a-7402-9554-6ae504999041", "version": 1, "description": null }, "function": "transition", "functionCanon": { "name": "Transition", "slug": "transition", "status": "active", "canonId": "019de52d-1365-7149-92aa-66df859e75fd", "version": 1, "description": null }, "density": "sparse", "densityScore": 4, "componentCount": 2, "textChars": 33, "nDataPoints": 0, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:43.724+00", "seconds": 2.461, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/7", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-7", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.83, "w": 0.305, "x": 0.025, "y": 0.125 }, "kind": "image", "text": null, "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Illustration", "slug": "illustration", "status": "active", "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615", "version": 1, "description": null }, "framework": null }, "subkind": "illustration", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:43.724+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "dcbe0782-cca4-4f51-97c5-3326284711d0", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.675, "x": 0.139, "y": 0.595 }, "kind": "title", "text": "BNC210 in Social Anxiety Disorder", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:43.724+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f4cae214-dbbb-4192-a3d6-647100661148", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 8, "type": "resolution", "title": "The chart uses a funnel-like visualization to show the narrowing of the target population from total prevalence to the specific opportunity for BNC210.", "function": "size_opportunity", "rawType": "market_sizing", "block": null, "metadata": { "slideType": "market_sizing", "slideTypeCanon": { "name": "Market sizing", "slug": "market_sizing", "status": "active", "canonId": "019de52d-08c8-756c-8664-733b73a7ee7b", "version": 1, "description": null }, "function": "size_opportunity", "functionCanon": { "name": "Size opportunity", "slug": "size_opportunity", "status": "active", "canonId": "019de52d-147b-7568-8828-a74a27697618", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 81, "componentCount": 7, "textChars": 892, "nDataPoints": 6, "notes": "The chart uses a funnel-like visualization to show the narrowing of the target population from total prevalence to the specific opportunity for BNC210.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:44.57+00", "seconds": 3.262, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/8", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-8", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.65, "w": 0.45, "x": 0.52, "y": 0.135 }, "kind": "chart", "text": "Funnel chart showing ~31M, ~18M, ~7M, and Opportunity for BNC210", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Funnel", "slug": "funnel", "status": "active", "canonId": "019de52d-02ae-73f8-9daa-84dddccbc459", "version": 1, "description": null }, "framework": null }, "subkind": "funnel", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:44.57+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "fbe93cd4-4e5e-478b-9f7b-5b4674fbf788", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.35, "x": 0.52, "y": 0.69 }, "kind": "list", "text": "Unmet medical need to large patient population. Advancement in care. No FDA-approved fast-acting competition. Ability to potentially achieve large market share.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:44.57+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "3d77ead9-70de-455f-8159-052759d2d298", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.45, "x": 0.04, "y": 0.55 }, "kind": "list", "text": "Amongst the largest mental health conditions with lifetime prevalence affecting >31M Americans. No FDA-approved fast-acting medications for as-needed treatment. Medications with the right pharmacokinetic profile and a novel mechanism are needed.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:44.57+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "efc584c7-9bee-4c60-b1ad-b44b9e82dcc3", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.38, "x": 0.12, "y": 0.21 }, "kind": "list", "text": "Social Anxiety Disorder (SAD), or Social Phobia, is a significant and persistent fear of social and performance-related situations. Includes anxiety from everyday social situations as well as 'Fear of Public Speaking'. A disorder that substantially impacts many people's daily lives.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:44.57+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f32cb88d-5bd2-4558-963e-7969aac0c34e", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.6, "x": 0.13, "y": 0.87 }, "kind": "source-note", "text": "Sources: US Census Bureau, NIMH, ADAA", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:44.57+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "54813a08-8166-4fa7-a024-7f8f9d49e11c", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.45, "x": 0.04, "y": 0.15 }, "kind": "title", "text": "Acute Anxiety in SAD Represents a Significant Unmet Need", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Action title", "slug": "action-title", "status": "active", "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d", "version": 1, "description": null }, "framework": null }, "subkind": "action-title", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:44.57+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ee452338-975c-4254-9364-9d116fd95355", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.45, "x": 0.07, "y": 0.03 }, "kind": "title", "text": "Targeting a Large Segment of the Anxiety Market", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:44.57+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "69e80c68-192b-49c8-82b4-e6428ae81828", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "7634036c-d8b1-4159-a7cf-1e089de6cc17", "evidence": "The funnel chart visualizes the narrowing of the total addressable market.", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 12:57:44.57+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 8, "frameworkName": "market-segmentation-pyramid" } ], "arcBeats": [ { "to": 8, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null }, "from": 8, "name": "Market Size", "beatId": "33329ff7-078b-49a3-8d13-511e2664c27b", "matchId": "cd74960b-1c5d-48f9-8531-0845487ffab4", "beatType": { "name": "Market Size", "slug": "sequoia-pitch-market-size", "status": "active", "canonId": "019dd9b8-20e6-729c-bc28-05442906d032", "version": 1, "description": null }, "evidence": "Market sizing is presented on page 8, targeting a large segment of the anxiety market.", "position": 2, "isPrimaryArc": true, "parentBeatType": { "name": "Evidence", "slug": "evidence", "status": "active", "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a", "version": 1, "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true }, { "page": 9, "type": "evidence", "title": "The slide uses a bar chart to visualize efficacy data from a small-scale human study.", "function": "show_traction", "rawType": "traction", "block": null, "metadata": { "slideType": "traction", "slideTypeCanon": { "name": "Traction", "slug": "traction", "status": "active", "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542", "version": 1, "description": null }, "function": "show_traction", "functionCanon": { "name": "Show traction", "slug": "show_traction", "status": "active", "canonId": "019de52d-16a8-756a-9b38-a7d35420561d", "version": 1, "description": null }, "density": "dense", "densityScore": 53, "componentCount": 5, "textChars": 411, "nDataPoints": 2, "notes": "The slide uses a bar chart to visualize efficacy data from a small-scale human study.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:44.226+00", "seconds": 2.589, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/9", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-9", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.1, "w": 0.65, "x": 0.25, "y": 0.75 }, "kind": "callout", "text": "BNC210 demonstrated reduction in panic symptoms and intensity as measured with the Panic Symptom Scale", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": null, "subkind": { "name": "Primary callout", "slug": "primary", "status": "active", "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d", "version": 1, "description": null }, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:44.226+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4ad0de06-5000-4592-800a-716b6182fb2f", "parentComponentId": null }, { "bbox": { "h": 0.6, "w": 0.65, "x": 0.25, "y": 0.15 }, "kind": "chart", "text": "Total # of Panic Symptoms and Panic Symptom Intensity", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Vertical bar chart", "slug": "bar-vertical", "status": "active", "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917", "version": 1, "description": null }, "framework": null }, "subkind": "bar-vertical", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:44.226+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "7fba68fd-0468-4467-9fd6-7afeaca4782e", "parentComponentId": null }, { "bbox": { "h": 0.5, "w": 0.2, "x": 0.05, "y": 0.25 }, "kind": "paragraph", "text": "Placebo-controlled study in 15 healthy volunteers who experienced a CCK-4-induced panic attack", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:44.226+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "9fdd8af9-816b-4a29-bd03-9fc5ee6fe126", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.4, "x": 0.13, "y": 0.88 }, "kind": "source-note", "text": "CCK-4 = Cholecystokinin Tetrapeptide (a peptide that induces anxiety and panic symptoms)", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:44.226+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "1532c9a1-777e-44ac-bdbe-05b300fba133", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.78, "x": 0.07, "y": 0.03 }, "kind": "title", "text": "BNC210 Significantly Reduced Panic Symptoms in Humans: CCK-4-Induced Model", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:44.226+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "262e630e-c178-40d6-a132-01b55d7870c1", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 10, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null }, "from": 9, "name": "Traction", "beatId": "50748b04-b9b4-4fc9-8bc4-af166cf1058b", "matchId": "cd74960b-1c5d-48f9-8531-0845487ffab4", "beatType": null, "evidence": "Traction is presented on pages 9-10, showcasing BNC210's efficacy in reducing panic symptoms and demonstrating acute anxiolytic activity.", "position": 3, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 10, "from": 9, "loop": { "name": "47_quick_win_big_bet", "slug": "47-quick-win-big-bet", "status": "active", "bestFor": "Transformation planning, 100-day plans, resource allocation", "canonId": "019dd956-790d-708d-983e-ef9bbc68f741", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "description": "Separate initiatives into immediate wins and longer-term strategic bets", "familyLabel": null }, "matchId": "5449b11f-140a-484b-a6d0-f26616247fcf", "evidence": "The traction section on pages 9-10 presents BNC210's efficacy in reducing panic symptoms and demonstrating acute anxiolytic activity.", "position": 2, "objective": "Can BNC210 provide a quick win in treating anxiety disorders?", "confidence": 0.6, "extraction": { "at": "2026-07-16 22:20:55.74398+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 10, "type": "evidence", "title": "Includes fMRI and behavioral task data from a 4-way crossover study.", "function": "show_traction", "rawType": "traction", "block": null, "metadata": { "slideType": "traction", "slideTypeCanon": { "name": "Traction", "slug": "traction", "status": "active", "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542", "version": 1, "description": null }, "function": "show_traction", "functionCanon": { "name": "Show traction", "slug": "show_traction", "status": "active", "canonId": "019de52d-16a8-756a-9b38-a7d35420561d", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 78, "componentCount": 7, "textChars": 688, "nDataPoints": 6, "notes": "Includes fMRI and behavioral task data from a 4-way crossover study.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:45.527+00", "seconds": 3.854, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/10", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-10", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.1, "w": 0.85, "x": 0.07, "y": 0.75 }, "kind": "callout", "text": "Amygdala activation is an imaging surrogate for anxiety. Connectivity between the amygdala and Anterior Cingulate Cortex (ACC) is very strong in high anxiety.", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": null, "subkind": { "name": "Primary callout", "slug": "primary", "status": "active", "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d", "version": 1, "description": null }, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.527+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "3bef5b0e-ff47-4b2f-b322-c746c63482df", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.2, "x": 0.35, "y": 0.45 }, "kind": "chart", "text": "Amygdala activation (L & R) for Placebo vs 300mg", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Grouped bar chart", "slug": "bar-grouped", "status": "active", "canonId": "019de52c-ff3b-751e-a8ff-f21ff11097b1", "version": 1, "description": null }, "framework": null }, "subkind": "bar-grouped", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.527+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "3210a246-bac6-4282-bf5c-eda04ff252a2", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.25, "x": 0.65, "y": 0.45 }, "kind": "chart", "text": "Mean Intensity of Defensive Behavior across 4 treatment arms", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Grouped bar chart", "slug": "bar-grouped", "status": "active", "canonId": "019de52c-ff3b-751e-a8ff-f21ff11097b1", "version": 1, "description": null }, "framework": null }, "subkind": "bar-grouped", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.527+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "eeea83b9-a682-43c0-9aa0-d7827d5c53c2", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.85, "x": 0.08, "y": 0.1 }, "kind": "diagram", "text": "4-way crossover study design: 24 GAD patients, 4 treatment arms, fearful faces task, JORT task, fMRI monitoring.", "attrs": null, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": { "name": "Process flow", "slug": "process", "status": "active", "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838", "version": 1, "description": null }, "framework": null }, "subkind": "process", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.527+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ca49ca7c-71ec-45b7-ab67-03a6ee633e57", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.5, "x": 0.13, "y": 0.88 }, "kind": "disclaimer", "text": "Wise T. et al., Biological Psychiatry 2020; Perkins A. et al., Translational Psychiatry 2021. GAD = Generalized Anxiety Disorder, JORT = Joystick Operated Runway Task, fMRI = Functional Magnetic Resonance Imaging", "attrs": null, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.527+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d010fac1-3b33-4cea-9d44-60cd157728ad", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.25, "x": 0.08, "y": 0.45 }, "kind": "image", "text": "Brain scan showing amygdala activation", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Illustration", "slug": "illustration", "status": "active", "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615", "version": 1, "description": null }, "framework": null }, "subkind": "illustration", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.527+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "28f60373-9931-4532-9b1a-907ee590d182", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.6, "x": 0.07, "y": 0.03 }, "kind": "title", "text": "BNC210 Demonstrated Acute Anxiolytic Activity in GAD Phase 2", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.527+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0e127bb8-a96e-4659-a801-0a78855fb9c9", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 10, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null }, "from": 9, "name": "Traction", "beatId": "50748b04-b9b4-4fc9-8bc4-af166cf1058b", "matchId": "cd74960b-1c5d-48f9-8531-0845487ffab4", "beatType": null, "evidence": "Traction is presented on pages 9-10, showcasing BNC210's efficacy in reducing panic symptoms and demonstrating acute anxiolytic activity.", "position": 3, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 10, "from": 9, "loop": { "name": "47_quick_win_big_bet", "slug": "47-quick-win-big-bet", "status": "active", "bestFor": "Transformation planning, 100-day plans, resource allocation", "canonId": "019dd956-790d-708d-983e-ef9bbc68f741", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "description": "Separate initiatives into immediate wins and longer-term strategic bets", "familyLabel": null }, "matchId": "5449b11f-140a-484b-a6d0-f26616247fcf", "evidence": "The traction section on pages 9-10 presents BNC210's efficacy in reducing panic symptoms and demonstrating acute anxiolytic activity.", "position": 2, "objective": "Can BNC210 provide a quick win in treating anxiety disorders?", "confidence": 0.6, "extraction": { "at": "2026-07-16 22:20:55.74398+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 11, "type": "setup", "title": "The slide uses a flywheel diagram to illustrate the benefits of BNC210 and a comparison table to validate the competitive advantage.", "function": "compare_peers", "rawType": "comparison_table", "block": null, "metadata": { "slideType": "comparison_table", "slideTypeCanon": { "name": "Comparison table", "slug": "comparison_table", "status": "active", "canonId": "019de52d-0a06-73f8-8813-fe022fab1de2", "version": 1, "description": null }, "function": "compare_peers", "functionCanon": { "name": "Compare peers", "slug": "compare_peers", "status": "active", "canonId": "019de52d-1453-72ba-a367-9ba3d34c1630", "version": 1, "description": null }, "density": "dense", "densityScore": 61, "componentCount": 6, "textChars": 534, "nDataPoints": 0, "notes": "The slide uses a flywheel diagram to illustrate the benefits of BNC210 and a comparison table to validate the competitive advantage.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:45.632+00", "seconds": 3.829, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/11", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-11", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.06, "w": 0.48, "x": 0.49, "y": 0.52 }, "kind": "callout", "text": "BNC210 IS DESIGNED TO PROVIDE ADVANTAGES COMPARED TO CURRENT THERAPIES*", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": null, "subkind": { "name": "Primary callout", "slug": "primary", "status": "active", "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d", "version": 1, "description": null }, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.632+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2492780e-f0ad-4e63-b4f2-8251c84b2e51", "parentComponentId": null }, { "bbox": { "h": 0.6, "w": 0.4, "x": 0.02, "y": 0.145 }, "kind": "diagram", "text": "Flywheel showing BNC210 benefits: Novel Mechanism, Attractive Pathway, Rapid Onset, Unique Formulation, Anti-Anxiety Effects", "attrs": null, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": { "name": "Hub and spoke", "slug": "hub-spoke", "status": "active", "canonId": "019de52d-04db-73e6-81ca-a234f2f23fc1", "version": 1, "description": null }, "framework": null }, "subkind": "hub-spoke", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.632+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d1ccc9a0-d873-4640-beeb-09a80033ffb1", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.75, "x": 0.13, "y": 0.87 }, "kind": "disclaimer", "text": "* Potential benefits based on analysis of data from separate studies and not on results that might have been obtained from head-to-head studies.", "attrs": null, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.632+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5512bbfb-6661-47c5-a95a-5573635cbdbb", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.48, "x": 0.49, "y": 0.62 }, "kind": "table", "text": "Comparison table of BNC210 against 5 criteria", "attrs": null, "canon": { "kind": { "name": "Table", "slug": "table", "status": "active", "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28", "version": 1, "description": "Tabular data layout." }, "tool": null, "subkind": { "name": "Data table", "slug": "data", "status": "active", "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569", "version": 1, "description": null }, "framework": null }, "subkind": "data", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.632+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "3bc77678-db7b-44f5-9842-e19f49d480f4", "parentComponentId": null }, { "bbox": { "h": 0.35, "w": 0.48, "x": 0.49, "y": 0.138 }, "kind": "table", "text": "Comparison table of Benzodiazepines and SSRIs/SNRIs against 5 criteria", "attrs": null, "canon": { "kind": { "name": "Table", "slug": "table", "status": "active", "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28", "version": 1, "description": "Tabular data layout." }, "tool": null, "subkind": { "name": "Data table", "slug": "data", "status": "active", "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569", "version": 1, "description": null }, "framework": null }, "subkind": "data", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.632+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "cc1b0313-c6cb-4172-b9ef-72aafafb90ce", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.8, "x": 0.07, "y": 0.03 }, "kind": "title", "text": "BNC210 Addresses the Shortcomings of Existing Social Anxiety Disorder Approaches", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.632+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "fd8da049-a1ad-4ca5-a2e9-05d35a2a3d5b", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "2x2 matrix", "slug": "matrix-2x2", "status": "active", "bestFor": null, "canonId": "019dd9e1-50ab-72d1-8afb-3ab0a38e32a8", "version": 1, "bodyDocId": null, "description": "BCG matrix, importance/urgency, any axes-and-quadrants frame.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "7c453584-0c63-4614-84cc-fe7edd4a50f2", "evidence": "table/data: Comparison table of Benzodiazepines and SSRIs/SNRIs against 5 criteria, table/data: Comparison table of BNC210 against 5 criteria", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-16 23:58:23.629409+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 11, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null }, { "tool": { "name": "Flywheel", "slug": "flywheel", "status": "active", "bestFor": null, "canonId": "019de52d-1ad8-75ab-9027-a40365590152", "version": 1, "bodyDocId": null, "description": null, "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "57119e88-dcff-4e27-96f0-e7fc20aaa70a", "evidence": "diagram/hub-spoke: Flywheel showing BNC210 benefits: Novel Mechanism, Attractive Pathway, Rapid Onset, Unique Formulation, Anti-Anxiety Effects", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-16 23:58:23.586721+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 11, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [ { "matchId": "a3c49f27-a548-4770-83fc-77c69a87cab8", "evidence": "Table comparing BNC210 to existing treatments", "framework": null, "confidence": 1, "extraction": { "at": "2026-05-02 12:57:45.632+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 11, "frameworkName": "comparison_table" }, { "matchId": "e360b125-92ae-4181-b1fe-10cd587a6e30", "evidence": "Circular diagram showing interconnected benefits of BNC210", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 12:57:45.632+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 11, "frameworkName": "flywheel" } ], "arcBeats": [], "loops": [], "locked": true }, { "page": 12, "type": "setup", "title": "Includes a pharmacokinetic chart showing concentration vs time for different doses.", "function": "argue_timing", "rawType": "why_now", "block": null, "metadata": { "slideType": "why_now", "slideTypeCanon": { "name": "Why now", "slug": "why_now", "status": "active", "canonId": "019de52d-0f2e-718d-b8ad-256dd87582d0", "version": 1, "description": null }, "function": "argue_timing", "functionCanon": { "name": "Argue timing (why now)", "slug": "argue_timing", "status": "active", "canonId": "019de52d-16f8-74de-9ec2-900be07d90dd", "version": 1, "description": null }, "density": "dense", "densityScore": 71, "componentCount": 6, "textChars": 642, "nDataPoints": 4, "notes": "Includes a pharmacokinetic chart showing concentration vs time for different doses.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:46.107+00", "seconds": 4.296, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/12", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-12", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.45, "w": 0.15, "x": 0.5, "y": 0.45 }, "kind": "callout", "text": "Maximum concentrations reached in ~45 – 105 min. across the dose range", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": null, "subkind": { "name": "Primary callout", "slug": "primary", "status": "active", "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d", "version": 1, "description": null }, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.107+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "61813440-046c-44f4-be1a-ec6a2efac8fb", "parentComponentId": null }, { "bbox": { "h": 0.45, "w": 0.3, "x": 0.65, "y": 0.45 }, "kind": "chart", "text": "Concentration versus Time", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Line chart", "slug": "line", "status": "active", "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677", "version": 1, "description": null }, "framework": null }, "subkind": "line", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.107+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "12a31357-f890-4c26-b88b-90cd3c8fea93", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.3, "x": 0.14, "y": 0.88 }, "kind": "disclaimer", "text": "*Based on path of CNS peer proceeding with registrational Phase 3 endpoint", "attrs": null, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.107+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "9a9c3f16-dae3-4ab2-8ded-11a1612dbd07", "parentComponentId": null }, { "bbox": { "h": 0.45, "w": 0.42, "x": 0.04, "y": 0.14 }, "kind": "list", "text": "Emerging Regulatory Landscape & Unmet Need: Benzodiazepines prescribed off-label have significant side effects; Growing unmet need; FDA precedent on simplified public speaking challenge endpoint.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.107+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "192cc429-0b43-43cc-af09-3c530f6e5de8", "parentComponentId": null }, { "bbox": { "h": 0.35, "w": 0.47, "x": 0.49, "y": 0.14 }, "kind": "list", "text": "Rapid Onset of Action with BNC210 Formulation: Clinically demonstrated potential for reducing anxiety; Observed acute anxiolytic efficacy similar to lorazepam; Formulation well-suited for acute dosing.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.107+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d8523b0c-e94e-450a-a185-9bca4534cfff", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.75, "x": 0.075, "y": 0.03 }, "kind": "title", "text": "BNC210's Rapid Onset of Action is Well-Positioned for Social Anxiety Disorder", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.107+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "45da1d5d-fe2d-4d13-9222-211577782080", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "List presentation", "slug": "list-presentation", "status": "active", "bestFor": null, "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1", "version": 1, "bodyDocId": null, "description": "Bulleted, numbered, or checklist enumerations.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "526cdb64-5721-4dd6-8960-cf5197ca0acc", "evidence": "list/bullet: Rapid Onset of Action with BNC210 Formulation: Clinically demonstrated potential for reducing anxiety; Observed acute anxiolytic efficacy similar to lorazepam; Formulation well-suited for acute dosing.", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.8, "extraction": { "at": "2026-07-16 23:58:23.715669+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 12, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null } ], "frameworks": [], "arcBeats": [ { "to": 12, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null }, "from": 12, "name": "Why Now", "beatId": "5a730e5a-abd5-4b84-8096-b3f5be8f655b", "matchId": "cd74960b-1c5d-48f9-8531-0845487ffab4", "beatType": { "name": "Why Now", "slug": "sequoia-pitch-why-now", "status": "active", "canonId": "019dd9b8-204f-77ee-82c8-8ebaf0870ff9", "version": 1, "description": null }, "evidence": "The why now section is presented on page 12, highlighting BNC210's rapid onset of action and its potential in Social Anxiety Disorder.", "position": 4, "isPrimaryArc": true, "parentBeatType": { "name": "Evidence", "slug": "evidence", "status": "active", "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a", "version": 1, "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true }, { "page": 13, "type": "resolution", "title": "The slide uses a process flow diagram to illustrate the clinical trial design.", "function": "plan_implementation", "rawType": "roadmap", "block": null, "metadata": { "slideType": "roadmap", "slideTypeCanon": { "name": "Roadmap", "slug": "roadmap", "status": "active", "canonId": "019de52d-0a55-72bc-9b7b-a47ef109839c", "version": 1, "description": null }, "function": "plan_implementation", "functionCanon": { "name": "Plan implementation", "slug": "plan_implementation", "status": "active", "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823", "version": 1, "description": null }, "density": "dense", "densityScore": 59, "componentCount": 5, "textChars": 491, "nDataPoints": 6, "notes": "The slide uses a process flow diagram to illustrate the clinical trial design.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:46.139+00", "seconds": 4.076, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/13", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-13", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.1, "w": 0.5, "x": 0.42, "y": 0.77 }, "kind": "callout", "text": "FDA Fast Track designation; Topline data YE'22", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": null, "subkind": { "name": "Primary callout", "slug": "primary", "status": "active", "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d", "version": 1, "description": null }, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.139+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "69fc4aee-2a36-4b0d-8b81-c2f5982b3fce", "parentComponentId": null }, { "bbox": { "h": 0.2, "w": 0.25, "x": 0.45, "y": 0.35 }, "kind": "chart", "text": "Randomization groups: 225mg, 675mg, Placebo", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Vertical bar chart", "slug": "bar-vertical", "status": "active", "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917", "version": 1, "description": null }, "framework": null }, "subkind": "bar-vertical", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.139+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "58a61b46-48a0-4034-9f8f-3420f8526f3d", "parentComponentId": null }, { "bbox": { "h": 0.5, "w": 0.3, "x": 0.43, "y": 0.18 }, "kind": "diagram", "text": "Phase 2 PREVAIL Study Design flow from Screening to Randomization to Single Anxiety Challenge", "attrs": null, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": { "name": "Process flow", "slug": "process", "status": "active", "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838", "version": 1, "description": null }, "framework": null }, "subkind": "process", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.139+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "1e7833a0-d02d-4816-a68e-98ebdaf5b360", "parentComponentId": null }, { "bbox": { "h": 0.4, "w": 0.38, "x": 0.03, "y": 0.15 }, "kind": "list", "text": "Cost-effective trial with an efficacy endpoint conducive to rapid data generation; Ability to leverage VistaGen’s development plan; Received FDA clearance for IND filing and FDA Fast Track designation; Phase 2 trial underway with topline data by end of 2022", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.139+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "9cb8bce2-ee5d-43c7-8a6b-e05987c4d705", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.5, "x": 0.07, "y": 0.03 }, "kind": "title", "text": "BNC210 Phase 2 PREVAIL Social Anxiety Disorder Trial", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.139+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "70fd096e-bf44-437d-8239-8ead42dd939b", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "fd6681cb-4c82-4f2c-b463-2de1f098f73a", "evidence": "Clinical trial design flow", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 12:57:46.139+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 13, "frameworkName": "process" } ], "arcBeats": [], "loops": [], "locked": true }, { "page": 14, "type": "setup", "function": "transition", "rawType": "section_divider", "block": null, "metadata": { "slideType": "section_divider", "slideTypeCanon": { "name": "Section divider", "slug": "section_divider", "status": "active", "canonId": "019de52d-066a-7402-9554-6ae504999041", "version": 1, "description": null }, "function": "transition", "functionCanon": { "name": "Transition", "slug": "transition", "status": "active", "canonId": "019de52d-1365-7149-92aa-66df859e75fd", "version": 1, "description": null }, "density": "sparse", "densityScore": 5, "componentCount": 2, "textChars": 40, "nDataPoints": 0, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:44.208+00", "seconds": 2.106, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/14", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-14", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.75, "w": 0.33, "x": 0.025, "y": 0.12 }, "kind": "image", "text": null, "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Illustration", "slug": "illustration", "status": "active", "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615", "version": 1, "description": null }, "framework": null }, "subkind": "illustration", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:44.208+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "096671fc-3456-4d1e-aff8-adf0101f27a1", "parentComponentId": null }, { "bbox": { "h": 0.12, "w": 0.535, "x": 0.139, "y": 0.595 }, "kind": "title", "text": "BNC210 in Post-Traumatic Stress Disorder", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:44.208+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ef6f712c-070b-4a51-9354-bba9d6d21ef7", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 15, "type": "tension", "title": "The slide uses a funnel-like visual to represent the patient population and market opportunity.", "function": "frame_problem", "rawType": "problem_statement", "block": null, "metadata": { "slideType": "problem_statement", "slideTypeCanon": { "name": "Problem statement", "slug": "problem_statement", "status": "active", "canonId": "019de52d-0879-768d-bba8-8da8a5a121d4", "version": 1, "description": null }, "function": "frame_problem", "functionCanon": { "name": "Frame problem", "slug": "frame_problem", "status": "active", "canonId": "019de52d-13db-753e-ad70-e9b2d0dab398", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 78, "componentCount": 6, "textChars": 1557, "nDataPoints": 6, "notes": "The slide uses a funnel-like visual to represent the patient population and market opportunity.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:45.85+00", "seconds": 3.709, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/15", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-15", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.75, "w": 0.42, "x": 0.54, "y": 0.12 }, "kind": "chart", "text": "~21M 8% of adults at some point in their lives; ~9M 3.4% prevalence in adults; ~7M 75% of adults inadequately treated; Opportunity for BNC210", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Funnel", "slug": "funnel", "status": "active", "canonId": "019de52d-02ae-73f8-9daa-84dddccbc459", "version": 1, "description": null }, "framework": null }, "subkind": "funnel", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.85+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "26b4cbb2-d647-485a-9e64-98bf3d79a25a", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.35, "x": 0.54, "y": 0.67 }, "kind": "list", "text": "Unmet medical need to large patient population; Advancement in care; No branded competition; Ability to potentially achieve large market share", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.85+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "7f624096-ac5e-4068-8ae4-1044f8114689", "parentComponentId": null }, { "bbox": { "h": 0.55, "w": 0.45, "x": 0.07, "y": 0.21 }, "kind": "list", "text": "70% of people will experience a traumatic event in their lifetime, but most people recover normally; PTSD results from exposure to actual or threatened death, serious injury or sexual violence; Affects up to 8% of adults during their lifetime; PTSD is a global mental health problem that is associated with significant morbidity and mortality and shows up in all facets of peoples' lives; No newly approved pharmacotherapy in almost two decades; Medications with a novel mechanism of action that can address the pathophysiology of PTSD are needed", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.85+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "dc258764-1547-484a-9f06-c66a587aedac", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.85, "x": 0.07, "y": 0.87 }, "kind": "source-note", "text": "1. Kilpatrick, D., Resnick, H., Milanak, M., Miller, M., Keyes, K. and Friedman, M., 2013. National Estimates of Exposure to Traumatic Events and PTSD Prevalence Using DSM-IV and DSM-5 Criteria. Journal of Traumatic Stress, 26(5), pp.537-547; 2 Mayo LM, Asratain A., Lindé J et al. Elevated Anandamide, Enhanced Recall of Fear Extinction, and Attenuated Stress Responses Following Inhibition of Fatty Acid Amide Hydrolase: A Randomized, Controlled Experimental Medicine Trial. Biol Psychiatry. 2020 Mar 15; 87(6): 538-544. Only 20 to 30% of PTSD patients achieve clinical remission on SSRI therapies. US Census Bureau.", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.85+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "e117f417-2330-4708-ac39-d3ed1e95da79", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.65, "x": 0.07, "y": 0.04 }, "kind": "title", "text": "Tackling the Profound Disease Burden of Post-Traumatic Stress Disorder", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.85+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2ce4a2a4-e1c4-45d9-bfe9-9a8d79db814c", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.45, "x": 0.07, "y": 0.16 }, "kind": "title", "text": "PTSD Represents a Significant Unmet Need", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.85+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a2178368-e73f-4b47-9c20-8d36586fe0ce", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "List presentation", "slug": "list-presentation", "status": "active", "bestFor": null, "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1", "version": 1, "bodyDocId": null, "description": "Bulleted, numbered, or checklist enumerations.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "6fe6a58b-7aba-4e49-a259-f98d2f76b629", "evidence": "list/bullet: 70% of people will experience a traumatic event in their lifetime, but most people recover normally; PTSD results from exposure to actual or threatened death, serious injury or sexual violence; Affects up to", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.8, "extraction": { "at": "2026-07-16 23:58:23.885942+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 15, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null } ], "frameworks": [], "arcBeats": [ { "to": 15, "arc": { "name": "The Sequoia Pitch", "slug": "sequoia-pitch", "status": "active", "bestFor": "Investor pitches, Series A/B, board presentations", "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask", "description": null, "familyLabel": null }, "from": 15, "name": "Problem", "beatId": "b1c78737-9b27-4aeb-b978-208a1cc9d0d6", "matchId": "cd74960b-1c5d-48f9-8531-0845487ffab4", "beatType": { "name": "Problem", "slug": "sequoia-pitch-problem", "status": "active", "canonId": "019dd9b8-1ed4-767b-8e05-40e733bd2311", "version": 1, "description": null }, "evidence": "The problem statement is presented on page 15, highlighting the disease burden of Post-Traumatic Stress Disorder.", "position": 0, "isPrimaryArc": true, "parentBeatType": { "name": "Complication", "slug": "complication", "status": "active", "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579", "version": 1, "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 15, "from": 15, "loop": { "name": "27_cost_of_inaction", "slug": "27-cost-of-inaction", "status": "active", "bestFor": "Urgent budget requests, compliance, risk mitigation", "canonId": "019dd956-70d1-7395-a15b-857ba858b394", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "description": "Quantify what happens if the audience does nothing", "familyLabel": null }, "matchId": "53e8a626-52c3-439a-8010-21e4ca9d800f", "evidence": "The problem statement on page 15 highlights the disease burden of PTSD.", "position": 1, "objective": "What is the cost of not treating PTSD effectively?", "confidence": 0.6, "extraction": { "at": "2026-07-16 22:20:55.710708+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 16, "type": "evidence", "title": "The slide uses a before-after-bridge style structure to connect the problem (anxiety/PTSD) to the solution (BNC210) via experimental evidence.", "function": "show_traction", "rawType": "traction", "block": null, "metadata": { "slideType": "traction", "slideTypeCanon": { "name": "Traction", "slug": "traction", "status": "active", "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542", "version": 1, "description": null }, "function": "show_traction", "functionCanon": { "name": "Show traction", "slug": "show_traction", "status": "active", "canonId": "019de52d-16a8-756a-9b38-a7d35420561d", "version": 1, "description": null }, "density": "dense", "densityScore": 74, "componentCount": 7, "textChars": 594, "nDataPoints": 2, "notes": "The slide uses a before-after-bridge style structure to connect the problem (anxiety/PTSD) to the solution (BNC210) via experimental evidence.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:46.33+00", "seconds": 3.859, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/16", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-16", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.65, "w": 0.21, "x": 0.02, "y": 0.17 }, "kind": "callout", "text": "People with anxiety disorders and PTSD have amplified fear responses to trauma- or stress-related stimuli and impaired fear extinction", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": null, "subkind": { "name": "Primary callout", "slug": "primary", "status": "active", "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d", "version": 1, "description": null }, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.33+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "070cb3fe-d83d-44c8-9fd4-3a60d78a1711", "parentComponentId": null }, { "bbox": { "h": 0.6, "w": 0.35, "x": 0.6, "y": 0.15 }, "kind": "chart", "text": "Emotional Visual Analog Scale (eVAS)", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Vertical bar chart", "slug": "bar-vertical", "status": "active", "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917", "version": 1, "description": null }, "framework": null }, "subkind": "bar-vertical", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.33+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "343bd286-4204-4e30-b3ee-e39db6eac273", "parentComponentId": null }, { "bbox": { "h": 0.6, "w": 0.3, "x": 0.25, "y": 0.15 }, "kind": "chart", "text": "Conditioned Fear Extinction Model", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Line chart", "slug": "line", "status": "active", "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677", "version": 1, "description": null }, "framework": null }, "subkind": "line", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.33+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "cc1db6a1-7282-4c5e-9db5-70613710c84e", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.4, "x": 0.13, "y": 0.87 }, "kind": "disclaimer", "text": "*Time in minutes after CCK-injection; CCK-4 = Cholecystokinin Tetrapeptide (a peptide that induces anxiety and panic symptoms); eVAS = Emotional Visual Analog Scale", "attrs": null, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.33+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "fc73070b-ff8c-4f30-946c-8de621f59628", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.32, "x": 0.24, "y": 0.74 }, "kind": "list", "text": "BNC210 enhanced fear extinction following conditioned response training", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Timeline item", "slug": "timeline-item", "status": "active", "canonId": "019de52c-fd0e-74ce-9443-440fbd8c23b4", "version": 1, "description": null }, "framework": null }, "subkind": "timeline-item", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.33+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "79d51441-cfba-4eec-a475-d5c755af055e", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.38, "x": 0.59, "y": 0.74 }, "kind": "list", "text": "BNC210 enhanced emotional recovery following a CCK-induced panic attack", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Timeline item", "slug": "timeline-item", "status": "active", "canonId": "019de52c-fd0e-74ce-9443-440fbd8c23b4", "version": 1, "description": null }, "framework": null }, "subkind": "timeline-item", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.33+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "9ba7a6d1-c03f-4307-9807-6a31905778b6", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.8, "x": 0.07, "y": 0.03 }, "kind": "title", "text": "BNC210 Anti-Anxiety Signals Observed in Animal Models and Human Translational Studies", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.33+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c8045a24-e784-436f-b4ce-041e687ab739", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "7fa5b35c-e1bc-406a-81f8-cdc231b9bd3f", "evidence": "The slide contrasts the problem (left callout) with the experimental results (charts) and the resulting benefits (bottom arrows).", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 12:57:46.33+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 16, "frameworkName": "before-after-bridge" } ], "arcBeats": [], "loops": [], "locked": true }, { "page": 17, "type": "resolution", "title": "The slide uses a process flow diagram to show the evolution of the drug development program.", "function": "plan_implementation", "rawType": "roadmap", "block": null, "metadata": { "slideType": "roadmap", "slideTypeCanon": { "name": "Roadmap", "slug": "roadmap", "status": "active", "canonId": "019de52d-0a55-72bc-9b7b-a47ef109839c", "version": 1, "description": null }, "function": "plan_implementation", "functionCanon": { "name": "Plan implementation", "slug": "plan_implementation", "status": "active", "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 77, "componentCount": 8, "textChars": 785, "nDataPoints": 0, "notes": "The slide uses a process flow diagram to show the evolution of the drug development program.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:49.667+00", "seconds": 7.171, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/17", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-17", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.7, "w": 0.94, "x": 0.03, "y": 0.15 }, "kind": "diagram", "text": "Five-stage development process flow", "attrs": null, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": { "name": "Process flow", "slug": "process", "status": "active", "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838", "version": 1, "description": null }, "framework": null }, "subkind": "process", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:49.667+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "03148ed5-46db-47a0-9908-8579df0729bf", "parentComponentId": null }, { "bbox": { "h": 0.35, "w": 0.18, "x": 0.8, "y": 0.45 }, "kind": "list", "text": "Phase 2b ATTUNE trial started in July 2021; Topline data expected 1H 2023", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:49.667+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "12574548-d6a5-48df-84ce-60c33b760d1d", "parentComponentId": null }, { "bbox": { "h": 0.35, "w": 0.18, "x": 0.23, "y": 0.45 }, "kind": "list", "text": "Pharmacometric analysis of Phase 2 PTSD data; Predicted significant efficacy potential with adequate drug exposure achieved", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:49.667+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "20a9fd7b-bc70-438f-a2ea-92843c2e62bc", "parentComponentId": null }, { "bbox": { "h": 0.35, "w": 0.18, "x": 0.04, "y": 0.45 }, "kind": "list", "text": "Anti-depressant and anti-anxiety trends seen at earlier time points; Safety profile generally well tolerated; Did not meet primary endpoint*; lower than expected exposure of liquid suspension formulation", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:49.667+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "957e7f2d-17b0-49c0-b485-ba0fdb5c2e4a", "parentComponentId": null }, { "bbox": { "h": 0.35, "w": 0.18, "x": 0.61, "y": 0.45 }, "kind": "list", "text": "Type C meeting with FDA; FDA granted Fast Track designation in PTSD", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:49.667+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "cdf6208f-f1db-4706-8822-ad96f11d69ec", "parentComponentId": null }, { "bbox": { "h": 0.35, "w": 0.18, "x": 0.42, "y": 0.45 }, "kind": "list", "text": "New tablet formulation overcomes food effect of suspension formulation; Achieved exposure target predicted from pharmacometric analysis; Extended IP coverage", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:49.667+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "cebff1d9-cf2a-45e8-b1eb-9a214cb60a57", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.3, "x": 0.13, "y": 0.88 }, "kind": "source-note", "text": "*Primary endpoint of CAPS-5 total symptom severity score at 12 weeks", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:49.667+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2feb53f8-1112-4e81-a4d3-b00c45f6ef15", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.6, "x": 0.07, "y": 0.03 }, "kind": "title", "text": "BNC210 is Well-Positioned in Post-Traumatic Stress Disorder", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:49.667+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "09d7ffe7-f922-4aa7-b4b4-db9f2dbe5cff", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "600c2aa8-7609-46bc-a079-1f83e569e8f2", "evidence": "Sequential flow of development stages", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 12:57:49.667+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 17, "frameworkName": "process" } ], "arcBeats": [], "loops": [], "locked": true }, { "page": 18, "type": "resolution", "title": "The slide uses a combination of exposure-response modeling and pharmacokinetic data to validate the new formulation.", "function": "present_solution", "rawType": "solution", "block": null, "metadata": { "slideType": "solution", "slideTypeCanon": { "name": "Solution", "slug": "solution", "status": "active", "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282", "version": 1, "description": null }, "function": "present_solution", "functionCanon": { "name": "Present solution", "slug": "present_solution", "status": "active", "canonId": "019de52d-15b8-71da-bd23-2b767850cbce", "version": 1, "description": null }, "density": "dense", "densityScore": 63, "componentCount": 6, "textChars": 457, "nDataPoints": 2, "notes": "The slide uses a combination of exposure-response modeling and pharmacokinetic data to validate the new formulation.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:45.979+00", "seconds": 3.392, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/18", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-18", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.1, "w": 0.35, "x": 0.6, "y": 0.0075 }, "kind": "callout", "text": "Novel tablet overcomes food effect and has dose linear exposure", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": null, "subkind": { "name": "Primary callout", "slug": "primary", "status": "active", "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d", "version": 1, "description": null }, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.979+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "365e3926-50f9-4f26-b6fd-85ed8cda99e5", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.35, "x": 0.22, "y": 0.0075 }, "kind": "callout", "text": "AUC Values (plasma exposure) = CAPS-5 Score (PTSD symptoms)", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": null, "subkind": { "name": "Primary callout", "slug": "primary", "status": "active", "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d", "version": 1, "description": null }, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.979+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "94abb57c-c91e-4e29-b935-c249cda96f5c", "parentComponentId": null }, { "bbox": { "h": 0.4, "w": 0.35, "x": 0.22, "y": 0.0022 }, "kind": "chart", "text": "Exposure-Response Curve", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Line chart", "slug": "line", "status": "active", "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677", "version": 1, "description": null }, "framework": null }, "subkind": "line", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.979+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2acb0f25-a241-4776-80ae-209c7d2a1eaa", "parentComponentId": null }, { "bbox": { "h": 0.4, "w": 0.35, "x": 0.6, "y": 0.0022 }, "kind": "chart", "text": "BNC210 Novel Spray Dry Dispersion Formulation PK profile", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Line chart", "slug": "line", "status": "active", "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677", "version": 1, "description": null }, "framework": null }, "subkind": "line", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.979+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "3d31e805-5d09-442b-a706-f73c4f678f95", "parentComponentId": null }, { "bbox": { "h": 0.4, "w": 0.18, "x": 0.02, "y": 0.0016 }, "kind": "list", "text": "PMX modelling on prior Phase 2 PTSD trial identified liquid suspension under-exposure; BNC210 tablet formulation; New formulation achieves target AUC >25 mg.hr/L with 900 mg dose b.i.d.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.979+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "01c8f57c-d3c1-4a16-92ed-c9ab79ea8fa5", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.75, "x": 0.07, "y": 0.03 }, "kind": "title", "text": "Pharmacometric Modeling Target Achieved with New Dose Solid Formulation", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.979+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "1480242d-4041-4ee6-b661-a5028b869092", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 19, "type": "resolution", "title": "The slide outlines a 12-week outpatient BID dosing period followed by a follow-up phase, with specific primary and secondary endpoints.", "function": "plan_implementation", "rawType": "roadmap", "block": null, "metadata": { "slideType": "roadmap", "slideTypeCanon": { "name": "Roadmap", "slug": "roadmap", "status": "active", "canonId": "019de52d-0a55-72bc-9b7b-a47ef109839c", "version": 1, "description": null }, "function": "plan_implementation", "functionCanon": { "name": "Plan implementation", "slug": "plan_implementation", "status": "active", "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 85, "componentCount": 8, "textChars": 937, "nDataPoints": 4, "notes": "The slide outlines a 12-week outpatient BID dosing period followed by a follow-up phase, with specific primary and secondary endpoints.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:48.018+00", "seconds": 5.164, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/19", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-19", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.1, "w": 0.35, "x": 0.3, "y": 0.075 }, "kind": "callout", "text": "Fast Track designation from FDA", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": null, "subkind": { "name": "Primary callout", "slug": "primary", "status": "active", "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d", "version": 1, "description": null }, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.018+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "b042be84-f131-4e31-99f2-39848a050776", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.32, "x": 0.66, "y": 0.075 }, "kind": "callout", "text": "Topline data expected 1H'23", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": null, "subkind": { "name": "Primary callout", "slug": "primary", "status": "active", "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d", "version": 1, "description": null }, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.018+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "dcee8a77-db32-447f-a077-69d7a7b880d5", "parentComponentId": null }, { "bbox": { "h": 0.35, "w": 0.5, "x": 0.15, "y": 0.15 }, "kind": "diagram", "text": "12-week study timeline with outpatient BID dosing and follow-up", "attrs": null, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": { "name": "Timeline", "slug": "timeline", "status": "active", "canonId": "019de52d-03c5-73fc-84aa-4180cbf0f5cf", "version": 1, "description": null }, "framework": null }, "subkind": "timeline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.018+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c7c82c30-cb9b-4672-8d14-8845757ca660", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.45, "x": 0.25, "y": 0.045 }, "kind": "list", "text": "SECONDARY ENDPOINTS: Various patient-reported symptoms of PTSD, changes in anxiety and depression symptoms, and global and social functioning; Safety & tolerability endpoints. PRIMARY ENDPOINT: Investigator-rated PTSD symptoms on CAPS-5 Total Symptom Severity Scores in change from Baseline to Week 12 compared to placebo", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.018+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "bf8dbc96-8066-4221-97b2-c18afdd91487", "parentComponentId": null }, { "bbox": { "h": 0.2, "w": 0.2, "x": 0.05, "y": 0.025 }, "kind": "paragraph", "text": "Phase 2b 1:1 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED BNC210 MONOTHERAPY IN PTSD PATIENTS ~200 Subjects", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.018+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2c09ec9c-08bc-4a8d-b9c8-51e79870901c", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.5, "x": 0.13, "y": 0.088 }, "kind": "source-note", "text": "BID = Twice daily dosing; CAPS-5 = Clinician-Administered PTSD Scale for the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5)", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.018+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "fd68057a-17de-49e9-bfa5-738978f93e23", "parentComponentId": null }, { "bbox": { "h": 0.6, "w": 0.25, "x": 0.73, "y": 0.012 }, "kind": "table", "text": "PHASE 2b: Single potential registrational-supporting trial for monotherapy treatment in PTSD. KEY INCLUSION CRITERIA: Female and male (18 – 75 years), Current PTSD diagnosis, CAPS-5 ≥ 30, ~25 Sites", "attrs": null, "canon": { "kind": { "name": "Table", "slug": "table", "status": "active", "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28", "version": 1, "description": "Tabular data layout." }, "tool": null, "subkind": { "name": "KPI table", "slug": "kpi", "status": "active", "canonId": "019de52d-0324-7799-a84e-d0885a8ad400", "version": 1, "description": null }, "framework": null }, "subkind": "kpi", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.018+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "e089be11-47dc-43ee-868a-00ecafc592eb", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.45, "x": 0.07, "y": 0.03 }, "kind": "title", "text": "BNC210 Phase 2b PTSD ATTUNE Study Underway", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.018+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c7a0da9e-31c4-4b15-b465-9c2d1bd878ad", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "0240f094-0ea3-4d4f-88ac-1383d276ddca", "evidence": "Timeline visualization of clinical trial phases", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 12:57:48.018+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 19, "frameworkName": "gantt-chart" } ], "arcBeats": [], "loops": [], "locked": true }, { "page": 20, "type": "setup", "title": "The slide features a stylized icon of a human head containing a group of people and a microscope, overlaid with a network/process graphic.", "function": "transition", "rawType": "section_divider", "block": null, "metadata": { "slideType": "section_divider", "slideTypeCanon": { "name": "Section divider", "slug": "section_divider", "status": "active", "canonId": "019de52d-066a-7402-9554-6ae504999041", "version": 1, "description": null }, "function": "transition", "functionCanon": { "name": "Transition", "slug": "transition", "status": "active", "canonId": "019de52d-1365-7149-92aa-66df859e75fd", "version": 1, "description": null }, "density": "sparse", "densityScore": 4, "componentCount": 2, "textChars": 26, "nDataPoints": 0, "notes": "The slide features a stylized icon of a human head containing a group of people and a microscope, overlaid with a network/process graphic.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:45.236+00", "seconds": 2.288, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/20", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-20", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.83, "w": 0.35, "x": 0.025, "y": 0.12 }, "kind": "image", "text": null, "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Illustration", "slug": "illustration", "status": "active", "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615", "version": 1, "description": null }, "framework": null }, "subkind": "illustration", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.236+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5649b133-d9aa-41dd-8da6-4b808ad8e999", "parentComponentId": null }, { "bbox": { "h": 0.045, "w": 0.36, "x": 0.139, "y": 0.585 }, "kind": "title", "text": "CNS-focused Collaborations", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.236+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "3486b00c-9c08-4036-a459-acab3dbadb65", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 21, "type": "evidence", "title": "The slide highlights a specific partnership with Merck, detailing financial milestones and clinical progress, supported by bar charts showing efficacy in animal", "function": "show_traction", "rawType": "traction", "block": null, "metadata": { "slideType": "traction", "slideTypeCanon": { "name": "Traction", "slug": "traction", "status": "active", "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542", "version": 1, "description": null }, "function": "show_traction", "functionCanon": { "name": "Show traction", "slug": "show_traction", "status": "active", "canonId": "019de52d-16a8-756a-9b38-a7d35420561d", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 75, "componentCount": 6, "textChars": 755, "nDataPoints": 15, "notes": "The slide highlights a specific partnership with Merck, detailing financial milestones and clinical progress, supported by bar charts showing efficacy in animal models.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:46.351+00", "seconds": 3.3, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/21", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-21", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.25, "w": 0.52, "x": 0.44, "y": 0.54 }, "kind": "chart", "text": "Snapshot of Early BNC375 Studies", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Vertical bar chart", "slug": "bar-vertical", "status": "active", "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917", "version": 1, "description": null }, "framework": null }, "subkind": "bar-vertical", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.351+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "17dd1a43-a949-4bdc-bc93-4ced837685a4", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.4, "x": 0.13, "y": 0.9 }, "kind": "disclaimer", "text": "Wang et al. J Pharmacol Exp Ther 373:311–324, May 2020. PAM = Positive allosteric modulator. MSD = A tradename of Merck & Co., Inc., Kenilworth NJ USA", "attrs": null, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.351+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0e5fc4d0-bc7f-486a-a654-8a021be1432e", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.35, "x": 0.04, "y": 0.58 }, "kind": "image", "text": "MERCK PARTNERSHIP", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.351+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "b04a05cf-9cab-403e-955c-2de762bfa9ed", "parentComponentId": null }, { "bbox": { "h": 0.18, "w": 0.82, "x": 0.14, "y": 0.12 }, "kind": "list", "text": "Entered into in 2014 to develop α7 receptor PAMs targeting cognitive dysfunction associated with Alzheimer’s disease and other central nervous system conditions. Merck funds all R&D activities. Milestone payments of US$20M upfront and US$10M in 2017. Eligible for up to US$465M in additional payments.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.351+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "134c627a-1c8d-40cb-bef6-5fc443649a74", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.82, "x": 0.14, "y": 0.33 }, "kind": "list", "text": "Includes 2 candidates in early-stage Phase 1 safety and biomarker clinical trials. 1st compound completed Phase 1 safety trials. In 2020, a second molecule was advanced by Merck into Phase 1 clinical trials.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.351+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "432c4cec-158b-4fb4-a11e-e03c2af1e4a7", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.45, "x": 0.09, "y": 0.03 }, "kind": "title", "text": "Ongoing Strategic Collaboration with Merck & Co.", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.351+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f9472278-cec4-4d00-9114-cb4ae590f7b6", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 22, "type": "evidence", "title": "The slide uses a newspaper graphic to frame the announcement as a significant news event.", "function": "show_traction", "rawType": "traction", "block": null, "metadata": { "slideType": "traction", "slideTypeCanon": { "name": "Traction", "slug": "traction", "status": "active", "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542", "version": 1, "description": null }, "function": "show_traction", "functionCanon": { "name": "Show traction", "slug": "show_traction", "status": "active", "canonId": "019de52d-16a8-756a-9b38-a7d35420561d", "version": 1, "description": null }, "density": "dense", "densityScore": 58, "componentCount": 5, "textChars": 726, "nDataPoints": 0, "notes": "The slide uses a newspaper graphic to frame the announcement as a significant news event.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 15:32:08.902+00", "seconds": 2.706, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/22", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-22", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.63, "w": 0.53, "x": 0.42, "y": 0.00138 }, "kind": "image", "text": "Newspaper graphic", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Illustration", "slug": "illustration", "status": "active", "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615", "version": 1, "description": null }, "framework": null }, "subkind": "illustration", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 15:32:08.902+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8befccff-51e1-47b3-a9f8-a94e0ba8035a", "parentComponentId": null }, { "bbox": { "h": 0.63, "w": 0.39, "x": 0.04, "y": 0.27 }, "kind": "image", "text": "EmpathBio logo", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 15:32:08.902+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8c4dfe44-d40c-40b5-ba49-5efee1cd5b8a", "parentComponentId": null }, { "bbox": { "h": 0.35, "w": 0.49, "x": 0.45, "y": 0.00495 }, "kind": "list", "text": "Initial collaborative framework of preclinical studies to collectively explore a combination drug treatment regimen with BNC210 and EMP-01. MDMA-assisted psychotherapy has demonstrated significant symptom improvement in PTSD patients. FDA has granted a Breakthrough Therapy designation to MDMA-assisted psychotherapy. EmpathBio is developing MDMA derivatives that may permit the entactogenic effects of MDMA to be separated from some of the known adverse effects. To explore the possibility of a combination treatment regimen warranting clinical evaluation.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 15:32:08.902+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "df98c796-d4ef-4b60-a1cb-717340535a39", "parentComponentId": null }, { "bbox": { "h": 0.07, "w": 0.31, "x": 0.04, "y": 0.66 }, "kind": "paragraph", "text": "EMP-01 = 3,4-Methylenedioxymethamphetamine (MDMA) derivative", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 15:32:08.902+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "adf906e1-7dab-4239-832b-346da320595b", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.82, "x": 0.09, "y": 0.04 }, "kind": "title", "text": "MOU for BNC210 and MDMA Derivative (EMP-01) for Post-Traumatic Stress Disorder", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 15:32:08.902+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5f7df32e-5300-4be9-9387-db1597b9ad72", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 23, "type": "setup", "function": "transition", "rawType": "section_divider", "block": null, "metadata": { "slideType": "section_divider", "slideTypeCanon": { "name": "Section divider", "slug": "section_divider", "status": "active", "canonId": "019de52d-066a-7402-9554-6ae504999041", "version": 1, "description": null }, "function": "transition", "functionCanon": { "name": "Transition", "slug": "transition", "status": "active", "canonId": "019de52d-1365-7149-92aa-66df859e75fd", "version": 1, "description": null }, "density": "sparse", "densityScore": 6, "componentCount": 2, "textChars": 55, "nDataPoints": 0, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:45.611+00", "seconds": 2.418, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/23", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-23", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.85, "w": 0.35, "x": 0.47, "y": 0.14 }, "kind": "image", "text": null, "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Illustration", "slug": "illustration", "status": "active", "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615", "version": 1, "description": null }, "framework": null }, "subkind": "illustration", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.611+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "fb3a6a52-c925-471f-bbe8-6d8b8dc7d1a0", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.45, "x": 0.11, "y": 0.63 }, "kind": "title", "text": "Investment Highlights & Stock and Financial Information", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.611+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "69ccb40d-f063-49e6-9c8d-13f14f966af2", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 24, "type": "evidence", "title": "Includes images of ASX and Nasdaq listing displays.", "function": "show_traction", "rawType": "traction", "block": null, "metadata": { "slideType": "traction", "slideTypeCanon": { "name": "Traction", "slug": "traction", "status": "active", "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542", "version": 1, "description": null }, "function": "show_traction", "functionCanon": { "name": "Show traction", "slug": "show_traction", "status": "active", "canonId": "019de52d-16a8-756a-9b38-a7d35420561d", "version": 1, "description": null }, "density": "dense", "densityScore": 53, "componentCount": 5, "textChars": 395, "nDataPoints": 3, "notes": "Includes images of ASX and Nasdaq listing displays.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:46.973+00", "seconds": 3.765, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/24", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-24", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.2, "w": 0.32, "x": 0.05, "y": 0.64 }, "kind": "image", "text": "Peiron, BVF Partners, Presight Capital, Merck", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo grid", "slug": "logo-grid", "status": "active", "canonId": "019de52c-fdd7-7409-93e5-81280a8ca215", "version": 1, "description": null }, "framework": null }, "subkind": "logo-grid", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.973+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "eeacfb2a-bdaf-4ebd-abaa-aea9d8132fca", "parentComponentId": null }, { "bbox": { "h": 0.82, "w": 0.54, "x": 0.43, "y": 0.13 }, "kind": "image", "text": "ASX and Nasdaq listing imagery", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Photo", "slug": "photo", "status": "active", "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875", "version": 1, "description": null }, "framework": null }, "subkind": "photo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.973+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "3e5d08a4-d0c4-4a83-abb7-27280ece1583", "parentComponentId": null }, { "bbox": { "h": 0.35, "w": 0.35, "x": 0.02, "y": 0.15 }, "kind": "list", "text": "Listing on two global exchanges; Lean operations with modest burn; Well-capitalized through CY2023; A$40.4M (US$29.2M) of net cash", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.973+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c458bfb9-4ce0-467a-85e2-55dcfe829b4f", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.4, "x": 0.14, "y": 0.88 }, "kind": "source-note", "text": "Figures as of December 31, 2021. US dollar figures illustrative- Based on exchange rate of 1.38 as published by the Reserve Bank of Australia as of Dec. 31, 2021.", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.973+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "fec32acd-51d8-4bff-9a96-6f42771fea74", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.3, "x": 0.08, "y": 0.04 }, "kind": "title", "text": "Stock and Financial Snapshot", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:46.973+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8ed75d16-9e95-4b45-bb63-b03702bb13c8", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 25, "type": "resolution", "title": "The slide uses a vertical timeline-like structure to present key strategic pillars.", "function": "summarize", "rawType": "key_takeaways", "block": null, "metadata": { "slideType": "key_takeaways", "slideTypeCanon": { "name": "Key takeaways", "slug": "key_takeaways", "status": "active", "canonId": "019de52d-06e7-7674-a891-9f7de3b11b6d", "version": 1, "description": null }, "function": "summarize", "functionCanon": { "name": "Summarize", "slug": "summarize", "status": "active", "canonId": "019de52d-1541-704f-b86f-bf7b75056373", "version": 1, "description": null }, "density": "balanced", "densityScore": 46, "componentCount": 4, "textChars": 591, "nDataPoints": 0, "notes": "The slide uses a vertical timeline-like structure to present key strategic pillars.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:51.323+00", "seconds": 7.856, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/25", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-25", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.75, "w": 0.83, "x": 0.13, "y": 0.12 }, "kind": "framework", "text": "Vertical timeline of strategic milestones", "attrs": null, "canon": { "kind": { "name": "Framework", "slug": "framework", "status": "active", "canonId": "019de52c-fa18-77c6-b10a-ccb8277ac0fa", "version": 1, "description": "Named conceptual framework instance." }, "tool": null, "subkind": { "name": "Framework instance", "slug": "instance", "status": "active", "canonId": "019de52d-05a2-72af-be0b-7edc60708a03", "version": 1, "description": null }, "framework": null }, "subkind": "instance", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:51.323+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c6311f3b-5541-444c-b473-13bf8969a346", "parentComponentId": null }, { "bbox": { "h": 0.72, "w": 0.77, "x": 0.19, "y": 0.14 }, "kind": "list", "text": "Diversified model with multiple value-driving clinical milestones expected in the next 4 – 6 quarters; BNC210's novel rapid onset formulation granted Fast Track designation for acute treatment of SAD; BNC210 Phase 2b ATTUNE PTSD study under way; Merck strategic partnership; Diverse early-stage pipeline; Well-capitalized balance sheet.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:51.323+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "44c59d59-29e9-4d40-8bb7-b549a7db98d1", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.7, "x": 0.13, "y": 0.91 }, "kind": "source-note", "text": "SAD = Social Anxiety Disorder; PTSD = Post-Traumatic Stress Disorder; 1. Wise T. et al, Biological Psychiatry 2020; Perkins A. et al, Translational Psychiatry 2021", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:51.323+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "04fb0cc8-0ea6-4a91-8b1d-4e35afeaf7f1", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.45, "x": 0.08, "y": 0.04 }, "kind": "title", "text": "Bionomics Outlook: Renewed Value-driving Trajectory", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:51.323+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "7244c8da-109c-4720-9d76-48b948f9d76a", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "Vertical Logic", "slug": "vertical-logic", "status": "active", "bestFor": null, "canonId": "019dd956-9a25-77b9-9302-04662b84c32b", "version": 1, "bodyDocId": null, "description": "Question/Answer flow down the hierarchy - each level answers Why? or How?", "familyLabel": null, "categoryName": "Loop", "categorySlug": "loop" }, "agent": "Architect", "layer": "slide", "agents": [ "Architect" ], "matchId": "99c14a9b-324f-46f4-808a-d9d7efb5f174", "evidence": "framework/instance: Vertical timeline of strategic milestones", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-16 23:58:17.089797+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 25, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [ { "matchId": "b31b990f-66e8-4ba7-b8a8-bc51d5b0b3b2", "evidence": "Vertical sequence of events and milestones", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 12:57:51.323+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 25, "frameworkName": "timeline" } ], "arcBeats": [], "loops": [], "locked": true }, { "page": 26, "type": "appendix", "function": "appendix", "rawType": "appendix", "block": null, "metadata": { "slideType": "appendix", "slideTypeCanon": { "name": "Appendix", "slug": "appendix", "status": "active", "canonId": "019de52d-0762-71f8-b564-89ab863301cc", "version": 1, "description": null }, "function": "appendix", "functionCanon": { "name": "Appendix", "slug": "appendix", "status": "active", "canonId": "019de52d-138d-750b-83c3-49b4bc7a7a38", "version": 1, "description": null }, "density": "sparse", "densityScore": 5, "componentCount": 2, "textChars": 46, "nDataPoints": 0, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:45.291+00", "seconds": 1.773, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/26", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-26", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.7, "w": 0.4, "x": 0.45, "y": 0.15 }, "kind": "image", "text": null, "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Illustration", "slug": "illustration", "status": "active", "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615", "version": 1, "description": null }, "framework": null }, "subkind": "illustration", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.291+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "85abd3d5-2288-4792-a1fb-06e1375755e4", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.55, "x": 0.11, "y": 0.64 }, "kind": "title", "text": "APPENDIX: Management Team & Board of Directors", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.291+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "37040fa3-65b1-4c5d-9b04-4a595017dee1", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 27, "type": "setup", "title": "The slide uses a combination of headshots for the management team and a list format for the board of directors, accompanied by a grid of corporate logos.", "function": "other", "rawType": "team_bio", "block": null, "metadata": { "slideType": "team_bio", "slideTypeCanon": { "name": "Team bio", "slug": "team_bio", "status": "active", "canonId": "019de52d-0a7d-7394-ae5b-037478e71f1e", "version": 1, "description": null }, "function": "other", "functionCanon": { "name": "Other (fallback)", "slug": "other", "status": "active", "canonId": "019de52d-15e1-75bc-99dc-07732380e2ce", "version": 1, "description": null }, "density": "dense", "densityScore": 56, "componentCount": 8, "textChars": 237, "nDataPoints": 0, "notes": "The slide uses a combination of headshots for the management team and a list format for the board of directors, accompanied by a grid of corporate logos.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:47.045+00", "seconds": 3.502, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/27", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-27", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.33, "w": 0.33, "x": 0.03, "y": 0.38 }, "kind": "image", "text": "Liz Doolin", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Headshot", "slug": "headshot", "status": "active", "canonId": "019de52c-fd5f-765c-9282-38b54f61bbbf", "version": 1, "description": null }, "framework": null }, "subkind": "headshot", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:47.045+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0915711d-c924-42a6-a8ae-47000d734248", "parentComponentId": null }, { "bbox": { "h": 0.33, "w": 0.33, "x": 0.35, "y": 0.38 }, "kind": "image", "text": "Adrian Hinton", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Headshot", "slug": "headshot", "status": "active", "canonId": "019de52c-fd5f-765c-9282-38b54f61bbbf", "version": 1, "description": null }, "framework": null }, "subkind": "headshot", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:47.045+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0f57e358-c76a-4cd5-8d8d-cc196d1cdb59", "parentComponentId": null }, { "bbox": { "h": 0.33, "w": 0.33, "x": 0.35, "y": 0.13 }, "kind": "image", "text": "Connor Bernstein", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Headshot", "slug": "headshot", "status": "active", "canonId": "019de52c-fd5f-765c-9282-38b54f61bbbf", "version": 1, "description": null }, "framework": null }, "subkind": "headshot", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:47.045+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "6b6d8019-8917-4c02-864e-c950fd110a9f", "parentComponentId": null }, { "bbox": { "h": 0.33, "w": 0.33, "x": 0.03, "y": 0.13 }, "kind": "image", "text": "Errol De Souza, PhD", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Headshot", "slug": "headshot", "status": "active", "canonId": "019de52c-fd5f-765c-9282-38b54f61bbbf", "version": 1, "description": null }, "framework": null }, "subkind": "headshot", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:47.045+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "dfc218f9-3d79-4e23-9112-9bfdc1f3f172", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.65, "x": 0.03, "y": 0.63 }, "kind": "image", "text": "Experience logos", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo grid", "slug": "logo-grid", "status": "active", "canonId": "019de52c-fdd7-7409-93e5-81280a8ca215", "version": 1, "description": null }, "framework": null }, "subkind": "logo-grid", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:47.045+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "9ea91a1c-7dee-4d90-aad0-6184e1313557", "parentComponentId": null }, { "bbox": { "h": 0.7, "w": 0.28, "x": 0.69, "y": 0.13 }, "kind": "list", "text": "Board of Directors list with associated company logos", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:47.045+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "3dfaff07-154a-4e05-982a-e89847cea22c", "parentComponentId": null }, { "bbox": { "h": 0.02, "w": 0.25, "x": 0.13, "y": 0.88 }, "kind": "source-note", "text": "1. Logos reflect experience in current and/or past roles.", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:47.045+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2c7a8018-fe27-46ed-a564-96c3201e203b", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.5, "x": 0.08, "y": 0.04 }, "kind": "title", "text": "Powered by a Seasoned and Experienced Management Team", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:47.045+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f753be67-5591-4d52-a2ee-0b56632f7226", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 28, "type": "appendix", "function": "appendix", "rawType": "appendix", "block": null, "metadata": { "slideType": "appendix", "slideTypeCanon": { "name": "Appendix", "slug": "appendix", "status": "active", "canonId": "019de52d-0762-71f8-b564-89ab863301cc", "version": 1, "description": null }, "function": "appendix", "functionCanon": { "name": "Appendix", "slug": "appendix", "status": "active", "canonId": "019de52d-138d-750b-83c3-49b4bc7a7a38", "version": 1, "description": null }, "density": "sparse", "densityScore": 5, "componentCount": 2, "textChars": 49, "nDataPoints": 0, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:45.615+00", "seconds": 1.89, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/28", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-28", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.85, "w": 0.35, "x": 0.47, "y": 0.14 }, "kind": "image", "text": null, "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Illustration", "slug": "illustration", "status": "active", "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615", "version": 1, "description": null }, "framework": null }, "subkind": "illustration", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.615+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4d493379-5d57-4aa1-8ab7-65afdc9cab16", "parentComponentId": null }, { "bbox": { "h": 0.12, "w": 0.65, "x": 0.11, "y": 0.64 }, "kind": "title", "text": "APPENDIX: BNC210 Prior Clinical Trial Information", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:45.615+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "b4c4b4fe-8ecc-408a-aca4-61a8fa600df6", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 29, "type": "resolution", "title": "The central hub describes the drug mechanism, while the four quadrants detail specific symptom clusters and corresponding evidence.", "function": "present_solution", "rawType": "solution", "block": null, "metadata": { "slideType": "solution", "slideTypeCanon": { "name": "Solution", "slug": "solution", "status": "active", "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282", "version": 1, "description": null }, "function": "present_solution", "functionCanon": { "name": "Present solution", "slug": "present_solution", "status": "active", "canonId": "019de52d-15b8-71da-bd23-2b767850cbce", "version": 1, "description": null }, "density": "dense", "densityScore": 66, "componentCount": 6, "textChars": 748, "nDataPoints": 0, "notes": "The central hub describes the drug mechanism, while the four quadrants detail specific symptom clusters and corresponding evidence.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:48.238+00", "seconds": 4.309, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/29", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-29", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.75, "w": 0.834, "x": 0.083, "y": 0.138 }, "kind": "diagram", "text": "BNC210 FOR PTSD MECHANISM & PHARMACOLOGY OF BNC210 (PRECLIN / CLIN) SUPPORT ITS THERAPEUTIC POTENTIAL FOR SEVERAL PTSD SYMPTOMS", "attrs": null, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": { "name": "Hub and spoke", "slug": "hub-spoke", "status": "active", "canonId": "019de52d-04db-73e6-81ca-a234f2f23fc1", "version": 1, "description": null }, "framework": null }, "subkind": "hub-spoke", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.238+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "bec4d1d1-8eb4-44b6-96bd-347dc02b9d28", "parentComponentId": null }, { "bbox": { "h": 0.12, "w": 0.28, "x": 0.098, "y": 0.188 }, "kind": "list", "text": "Enhanced fear extinction in mice and emotional recovery in humans following panic attack (CCK-4 Trial)", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.238+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0b770564-cbe0-4d2c-b036-8ab9cee9b0bd", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.21, "x": 0.705, "y": 0.165 }, "kind": "list", "text": "Reduced threat avoidance behavior in humans (GAD Phase 2) and several animal models of (threat); Reduced number and intensity panic symptoms and intensity in humans (CCK4 challenge Phase 1)", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.238+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "190b1a62-1d51-4445-bf8d-2cede160022d", "parentComponentId": null }, { "bbox": { "h": 0.12, "w": 0.28, "x": 0.098, "y": 0.685 }, "kind": "list", "text": "Antidepressant effect trends at early time points in PTSD patients (Phase 2B Study); Antidepressant effects in rodent model of depression", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.238+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "73a70a9f-8001-4122-83cd-67bdb71b4c34", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.21, "x": 0.705, "y": 0.515 }, "kind": "list", "text": "Reduces amygdala hyperactivity; Reduced anxious behavior in rodent models; Inhibition of a7 nAChR inhibits release of excitatory neurotransmitters", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.238+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "b972e145-2478-4241-ab76-16f4dc355790", "parentComponentId": null }, { "bbox": { "h": 0.032, "w": 0.491, "x": 0.076, "y": 0.035 }, "kind": "title", "text": "Compelling Rationale in a Multifaceted Disorder", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.238+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "12abda69-7207-4cc7-abbf-d3612e3d258a", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "d7afe2ae-2b69-4fdf-89a4-534003d36f90", "evidence": "Central hub with four surrounding quadrants representing symptom domains", "framework": null, "confidence": 1, "extraction": { "at": "2026-05-02 12:57:48.238+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 29, "frameworkName": "hub-spoke" } ], "arcBeats": [], "loops": [], "locked": true }, { "page": 30, "type": "analysis", "title": "The table provides a comprehensive overview of clinical trial progress across multiple phases and indications.", "function": "analyze_data", "rawType": "appendix_data", "block": null, "metadata": { "slideType": "appendix_data", "slideTypeCanon": { "name": "Appendix data", "slug": "appendix_data", "status": "active", "canonId": "019de52d-078a-745b-9ee4-c15f2f539acd", "version": 1, "description": null }, "function": "analyze_data", "functionCanon": { "name": "Analyze data", "slug": "analyze_data", "status": "active", "canonId": "019de52d-1590-7413-8c82-cc218cff40b4", "version": 1, "description": null }, "density": "balanced", "densityScore": 42, "componentCount": 3, "textChars": 445, "nDataPoints": 13, "notes": "The table provides a comprehensive overview of clinical trial progress across multiple phases and indications.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:51.26+00", "seconds": 6.966, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/30", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-30", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.06, "w": 0.45, "x": 0.13, "y": 0.88 }, "kind": "source-note", "text": "* The number of enrolled subjects who were administered BNC210; other enrolled subjects were administered placebo only. CCK-4 = Cholecystokinin Tetrapeptide. EEG = Electroencephalography. PK = Pharmacokinetic", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:51.26+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "9fd2adb1-52bc-4156-a3dd-5312f099c653", "parentComponentId": null }, { "bbox": { "h": 0.75, "w": 0.94, "x": 0.03, "y": 0.12 }, "kind": "table", "text": "Clinical trial data table with columns: Phase, Description, Participants/Setting, Subjects Enrolled, Formulation/Doses, Location", "attrs": null, "canon": { "kind": { "name": "Table", "slug": "table", "status": "active", "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28", "version": 1, "description": "Tabular data layout." }, "tool": null, "subkind": { "name": "Data table", "slug": "data", "status": "active", "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569", "version": 1, "description": null }, "framework": null }, "subkind": "data", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:51.26+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "bf8a58a3-2a0d-41f6-9704-d12a6347f3f5", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.75, "x": 0.06, "y": 0.05 }, "kind": "title", "text": "Summary of BNC210 Clinical Trials: Excellent Safety and Tolerability Profile in Healthy Subjects and Patients", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:51.26+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c2a4b7e9-1ad0-4984-b7e6-e6a8cf7192b1", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "Table data", "slug": "table-data", "status": "active", "bestFor": null, "canonId": "019dd9e1-4fab-7168-a82f-b847350a006d", "version": 1, "bodyDocId": null, "description": "Tabular layouts of structured data.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "957c02cb-3d67-46b2-b5d5-02eac9403229", "evidence": "table/data: Clinical trial data table with columns: Phase, Description, Participants/Setting, Subjects Enrolled, Formulation/Doses, Location", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-16 23:58:17.333184+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 30, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null } ], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 31, "type": "resolution", "title": "The slide uses a combination of a line chart showing dose-response reduction and a process flow diagram to explain the mechanism of action.", "function": "present_solution", "rawType": "solution", "block": null, "metadata": { "slideType": "solution", "slideTypeCanon": { "name": "Solution", "slug": "solution", "status": "active", "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282", "version": 1, "description": null }, "function": "present_solution", "functionCanon": { "name": "Present solution", "slug": "present_solution", "status": "active", "canonId": "019de52d-15b8-71da-bd23-2b767850cbce", "version": 1, "description": null }, "density": "dense", "densityScore": 71, "componentCount": 6, "textChars": 620, "nDataPoints": 8, "notes": "The slide uses a combination of a line chart showing dose-response reduction and a process flow diagram to explain the mechanism of action.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:48.219+00", "seconds": 3.85, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/31", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-31", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.7, "w": 0.17, "x": 0.03, "y": 0.165 }, "kind": "callout", "text": "BNC210 blood-brain barrier penetration and nicotinic receptor target engagement in humans", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": null, "subkind": { "name": "Primary callout", "slug": "primary", "status": "active", "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d", "version": 1, "description": null }, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.219+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "88eaae99-2532-41c5-ad59-45ed41cd8d85", "parentComponentId": null }, { "bbox": { "h": 0.12, "w": 0.73, "x": 0.22, "y": 0.75 }, "kind": "callout", "text": "Observed reduction in EEG response due to BNC210's negative allosteric modulation of the α7 receptors", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": null, "subkind": { "name": "Primary callout", "slug": "primary", "status": "active", "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d", "version": 1, "description": null }, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.219+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d3d70990-f2e0-4c6a-b7c2-4af9f4048069", "parentComponentId": null }, { "bbox": { "h": 0.55, "w": 0.38, "x": 0.22, "y": 0.15 }, "kind": "chart", "text": "BNC210 Reduced Nicotine-induced EEG Responses", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Line chart", "slug": "line", "status": "active", "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677", "version": 1, "description": null }, "framework": null }, "subkind": "line", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.219+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ff4e8c19-bfa2-4964-b1d5-624401df09f7", "parentComponentId": null }, { "bbox": { "h": 0.45, "w": 0.3, "x": 0.65, "y": 0.18 }, "kind": "diagram", "text": "Activation of nicotinic receptors in the brain induces EEG response; α4β2 and α7 receptors are the major nAChR populations targeted; BNC210 daily oral dosing reduced nicotine-induced EEG in the α2 band", "attrs": null, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": { "name": "Process flow", "slug": "process", "status": "active", "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838", "version": 1, "description": null }, "framework": null }, "subkind": "process", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.219+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2e041698-995e-44b0-afde-7f5016f041df", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.25, "x": 0.13, "y": 0.87 }, "kind": "source-note", "text": "nAChR = Nicotinic Acetylcholine Receptor; EEG = Electroencephalography; * p-value less than 0.05; ** p-value less than 0.01", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.219+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2522e086-48fc-4d47-81e3-45b9bcfff57b", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.6, "x": 0.07, "y": 0.03 }, "kind": "title", "text": "Mechanistic Validation of BNC210 as Evidenced by EEG Response", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.219+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "396dfcba-550e-47db-b1e9-dffc8b4e9c13", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "4145331a-c7e8-4554-81ba-67247acbd918", "evidence": "The process diagram links receptor activation to drug dosing and observed EEG reduction.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 12:57:48.219+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 31, "frameworkName": "causal-chain" } ], "arcBeats": [], "loops": [], "locked": true }, { "page": 32, "type": "setup", "title": "The slide uses a structured table layout to define the clinical trial parameters.", "function": "present_framework", "rawType": "appendix_methodology", "block": null, "metadata": { "slideType": "appendix_methodology", "slideTypeCanon": { "name": "Appendix methodology", "slug": "appendix_methodology", "status": "active", "canonId": "019de52d-07d9-726c-8599-167f2d2ffaa7", "version": 1, "description": null }, "function": "present_framework", "functionCanon": { "name": "Present framework", "slug": "present_framework", "status": "active", "canonId": "019de52d-1403-7667-9100-d2ac6709f750", "version": 1, "description": null }, "density": "balanced", "densityScore": 40, "componentCount": 3, "textChars": 434, "nDataPoints": 5, "notes": "The slide uses a structured table layout to define the clinical trial parameters.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:49.746+00", "seconds": 5.326, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/32", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-32", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.75, "w": 0.25, "x": 0.02, "y": 0.12 }, "kind": "image", "text": null, "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Illustration", "slug": "illustration", "status": "active", "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615", "version": 1, "description": null }, "framework": null }, "subkind": "illustration", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:49.746+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c428bf39-9f1a-4415-a0ce-48051ef90727", "parentComponentId": null }, { "bbox": { "h": 0.65, "w": 0.65, "x": 0.28, "y": 0.0012 }, "kind": "table", "text": "Study Design: Multi-center, randomized, double-blind, placebo-controlled; BNC210 150 mg, 300 mg, 600 mg and placebo (1:1:1:1); 12-week treatment period; 193 participants; 20 US sites / 6 Australian sites. Key Selection Criteria: Current diagnosis of PTSD as defined by CAPS-5. Key Study Objectives: Assess effects on symptoms; assess safety and tolerability.", "attrs": null, "canon": { "kind": { "name": "Table", "slug": "table", "status": "active", "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28", "version": 1, "description": "Tabular data layout." }, "tool": null, "subkind": { "name": "Data table", "slug": "data", "status": "active", "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569", "version": 1, "description": null }, "framework": null }, "subkind": "data", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:49.746+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5ec1d789-6a3b-4f88-a9b2-87f2d9895f67", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.65, "x": 0.07, "y": 0.03 }, "kind": "title", "text": "Phase 2 Trial of BNC210 in Adults with Post-Traumatic Stress Disorder (PTSD)", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:49.746+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f162f9ba-ba64-425f-823e-b00b6e180889", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "Table data", "slug": "table-data", "status": "active", "bestFor": null, "canonId": "019dd9e1-4fab-7168-a82f-b847350a006d", "version": 1, "bodyDocId": null, "description": "Tabular layouts of structured data.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "slide", "agents": null, "matchId": "ae7f4df9-bb04-47cd-b7bd-ac7389daf463", "evidence": "table/data: Study Design: Multi-center, randomized, double-blind, placebo-controlled; BNC210 150 mg, 300 mg, 600 mg and placebo (1:1:1:1); 12-week treatment period; 193 participants; 20 US sites / 6 Australian sites. Key", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-16 23:58:17.455792+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 32, "whyItWorks": null, "antipattern": null, "cardinality": "common", "narrativePurpose": null } ], "frameworks": [ { "matchId": "c64663e8-018a-4c0b-871d-c12b39de8b18", "evidence": "Structured presentation of study design, criteria, and objectives.", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 12:57:49.746+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 32, "frameworkName": "clinical-trial-design" } ], "arcBeats": [], "loops": [], "locked": true }, { "page": 33, "type": "resolution", "title": "The slide uses a mix of bullet points and a callout box for the 'reasons' section.", "function": "summarize", "rawType": "key_takeaways", "block": null, "metadata": { "slideType": "key_takeaways", "slideTypeCanon": { "name": "Key takeaways", "slug": "key_takeaways", "status": "active", "canonId": "019de52d-06e7-7674-a891-9f7de3b11b6d", "version": 1, "description": null }, "function": "summarize", "functionCanon": { "name": "Summarize", "slug": "summarize", "status": "active", "canonId": "019de52d-1541-704f-b86f-bf7b75056373", "version": 1, "description": null }, "density": "balanced", "densityScore": 48, "componentCount": 3, "textChars": 699, "nDataPoints": 6, "notes": "The slide uses a mix of bullet points and a callout box for the 'reasons' section.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:47.114+00", "seconds": 2.585, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/33", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-33", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.22, "w": 0.94, "x": 0.03, "y": 0.698 }, "kind": "callout", "text": "Potential reasons why clinically significant effects and trends seen at early time points did not translate into significant primary endpoint on CAPS-5 at 12 Weeks\nInadequate overall blood exposure of BNC210\nLower compliance with liquid suspension formulation which needed to be taken with food", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": null, "subkind": { "name": "Primary callout", "slug": "primary", "status": "active", "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d", "version": 1, "description": null }, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:47.114+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "aef1c414-9f63-4ff8-96df-e62f5df5c33e", "parentComponentId": null }, { "bbox": { "h": 0.55, "w": 0.92, "x": 0.04, "y": 0.11 }, "kind": "list", "text": "No overall effect on primary endpoint of CAPS-5 total severity score at 12 weeks\nAustralian patients had a greater improvement over placebo than US patients\nEvidence of antidepressant effect in high dose treatment group in total population\nTrend for anxiolytic effect in high dose treatment group in the total population\nBNC210 was well tolerated in patients with PTSD", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:47.114+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ba2d9903-0c29-4c61-8c5f-a923e2007d84", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.4, "x": 0.07, "y": 0.03 }, "kind": "title", "text": "BNC210 PTSD Trial Overall Conclusions", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:47.114+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4c1e7e23-ca45-42b8-a905-e1303b291e8f", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 34, "type": "setup", "title": "The slide features a stylized illustration of neurons, reinforcing the CNS (Central Nervous System) theme.", "function": "transition", "rawType": "section_divider", "block": null, "metadata": { "slideType": "section_divider", "slideTypeCanon": { "name": "Section divider", "slug": "section_divider", "status": "active", "canonId": "019de52d-066a-7402-9554-6ae504999041", "version": 1, "description": null }, "function": "transition", "functionCanon": { "name": "Transition", "slug": "transition", "status": "active", "canonId": "019de52d-1365-7149-92aa-66df859e75fd", "version": 1, "description": null }, "density": "sparse", "densityScore": 4, "componentCount": 2, "textChars": 36, "nDataPoints": 0, "notes": "The slide features a stylized illustration of neurons, reinforcing the CNS (Central Nervous System) theme.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:49.785+00", "seconds": 4.85, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/34", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-34", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.75, "w": 0.27, "x": 0.63, "y": 0.13 }, "kind": "image", "text": null, "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Illustration", "slug": "illustration", "status": "active", "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615", "version": 1, "description": null }, "framework": null }, "subkind": "illustration", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:49.785+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "28481a81-d98e-4f6a-82b6-ae7119127924", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.45, "x": 0.11, "y": 0.64 }, "kind": "title", "text": "Emerging CNS Pipeline for Partnering", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:49.785+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "15d8ac6e-8386-4e10-ba35-8fa651df9e5a", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 35, "type": "evidence", "title": "The chart shows reversal of PCP-induced cognitive deficits in mice, with BL-76 showing dose-dependent efficacy.", "function": "show_traction", "rawType": "traction", "block": null, "metadata": { "slideType": "traction", "slideTypeCanon": { "name": "Traction", "slug": "traction", "status": "active", "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542", "version": 1, "description": null }, "function": "show_traction", "functionCanon": { "name": "Show traction", "slug": "show_traction", "status": "active", "canonId": "019de52d-16a8-756a-9b38-a7d35420561d", "version": 1, "description": null }, "density": "dense", "densityScore": 69, "componentCount": 6, "textChars": 571, "nDataPoints": 6, "notes": "The chart shows reversal of PCP-induced cognitive deficits in mice, with BL-76 showing dose-dependent efficacy.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:48.605+00", "seconds": 3.613, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/35", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-35", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.15, "w": 0.4, "x": 0.07, "y": 0.12 }, "kind": "callout", "text": "Promising therapeutic strategy for improving cognitive disfunction and social withdrawal symptoms", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": null, "subkind": { "name": "Primary callout", "slug": "primary", "status": "active", "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d", "version": 1, "description": null }, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.605+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ac324e4a-3338-4622-beb0-3a2d7ab840f6", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.46, "x": 0.46, "y": 0.12 }, "kind": "callout", "text": "Potential in schizophrenia, Autism Spectrum disorders and conditions with cognitive impairments", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": null, "subkind": { "name": "Primary callout", "slug": "primary", "status": "active", "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d", "version": 1, "description": null }, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.605+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ca90d8b9-7c55-4eb1-909e-3d8eec0f4a58", "parentComponentId": null }, { "bbox": { "h": 0.55, "w": 0.52, "x": 0.41, "y": 0.3 }, "kind": "chart", "text": "Lead Compound BL-76 Fully Reverses PCP-induced Cognitive Deficit in Mice in the T-maze", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Vertical bar chart", "slug": "bar-vertical", "status": "active", "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917", "version": 1, "description": null }, "framework": null }, "subkind": "bar-vertical", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.605+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "46e8816d-f26c-4108-bf2c-b4bf4a394b45", "parentComponentId": null }, { "bbox": { "h": 0.55, "w": 0.33, "x": 0.07, "y": 0.31 }, "kind": "diagram", "text": "~600 COMPOUNDS SYNTHESIZED, 2 SERIES PATENTED, Lead Compound BL-76, Back-up Compounds", "attrs": null, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": { "name": "Process flow", "slug": "process", "status": "active", "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838", "version": 1, "description": null }, "framework": null }, "subkind": "process", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.605+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "e6886159-473e-4681-bd17-2cc3447de77e", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.45, "x": 0.41, "y": 0.29 }, "kind": "paragraph", "text": "Bionomics' molecules target Kv3.1/3.2 ion channels on parvalbumin positive, gabaergic interneurons in the pre-frontal cortex", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.605+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "72db1531-c2b5-48bf-8977-93326fddeb8f", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.8, "x": 0.07, "y": 0.03 }, "kind": "title", "text": "Kv3.1 / Kv3.2 Ion Channel Activators for Cognitive Dysfunction and Negative Symptoms", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.605+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "b14e1ea4-103b-4196-b5a4-cc558360ecaf", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "AIDA Model", "slug": "aida-model", "status": "active", "bestFor": null, "canonId": "019dd956-86fc-773c-813f-d416714b8413", "version": 1, "bodyDocId": null, "description": "Attention, Interest, Desire, Action - classic persuasion sequence", "familyLabel": null, "categoryName": "Block", "categorySlug": "block" }, "agent": "Storyteller", "layer": "slide", "agents": [ "Storyteller" ], "matchId": "162cc8d1-ffea-490c-8cc7-ae7ad046d967", "evidence": "The slide presents a clear attention-grabbing headline, followed by a brief description of the therapeutic strategy, and supporting evidence from a lead compound, which aligns with the AIDA model's structure of Attention, Interest, Desire, and Action.", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-16 23:58:06.446073+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 35, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 36, "type": "resolution", "title": "The slide uses a process-flow style layout to connect genetic rationale to compound development and preclinical results.", "function": "present_solution", "rawType": "solution", "block": null, "metadata": { "slideType": "solution", "slideTypeCanon": { "name": "Solution", "slug": "solution", "status": "active", "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282", "version": 1, "description": null }, "function": "present_solution", "functionCanon": { "name": "Present solution", "slug": "present_solution", "status": "active", "canonId": "019de52d-15b8-71da-bd23-2b767850cbce", "version": 1, "description": null }, "density": "dense", "densityScore": 59, "componentCount": 5, "textChars": 559, "nDataPoints": 2, "notes": "The slide uses a process-flow style layout to connect genetic rationale to compound development and preclinical results.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:48.15+00", "seconds": 3.09, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/36", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-36", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.4, "w": 0.28, "x": 0.67, "y": 0.37 }, "kind": "callout", "text": "Lead Candidate Identified: BL-017881; OBSERVED TO REVERSE PAIN IN THE FORMALIN PAW MODEL IN MICE", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": null, "subkind": { "name": "Primary callout", "slug": "primary", "status": "active", "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d", "version": 1, "description": null }, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.15+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "defef0bf-9c72-46f1-a2ad-cb046de75629", "parentComponentId": null }, { "bbox": { "h": 0.2, "w": 0.9, "x": 0.05, "y": 0.12 }, "kind": "diagram", "text": "Disease-Related Genetics -> Gain & Loss-of-function mutations in Nav1.7, 1.8 and 1.9 -> Associated with human pain syndromes where extreme pain or no pain is experienced", "attrs": null, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": { "name": "Process flow", "slug": "process", "status": "active", "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838", "version": 1, "description": null }, "framework": null }, "subkind": "process", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.15+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "cf942eec-4d75-4b52-9680-e9520189961a", "parentComponentId": null }, { "bbox": { "h": 0.4, "w": 0.25, "x": 0.38, "y": 0.37 }, "kind": "list", "text": "1000+ COMPOUNDS SYNTHESIZED; 2 SERIES PATENTED; 3 Patents Published", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.15+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0f708898-6aba-41f6-9d25-18431ee833a6", "parentComponentId": null }, { "bbox": { "h": 0.4, "w": 0.28, "x": 0.05, "y": 0.037 }, "kind": "paragraph", "text": "BNO Pan Nav inhibitors: Small molecules with functional selectivity for voltage gated sodium channels: Nav1.7, Nav1.8 and potentially Nav1.9", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.15+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c01b9b9e-ceb0-48b7-8fa3-43cdb171f585", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.8, "x": 0.07, "y": 0.03 }, "kind": "title", "text": "Pan Nav Inhibitors: Potential Non-Addictive, Reduced Side-Effect Chronic Pain Therapies", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:48.15+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4c2d567f-1184-4a4f-9dd1-b815cc88382f", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "AIDA Model", "slug": "aida-model", "status": "active", "bestFor": null, "canonId": "019dd956-86fc-773c-813f-d416714b8413", "version": 1, "bodyDocId": null, "description": "Attention, Interest, Desire, Action - classic persuasion sequence", "familyLabel": null, "categoryName": "Block", "categorySlug": "block" }, "agent": "Storyteller", "layer": "slide", "agents": [ "Storyteller" ], "matchId": "0c1dda3e-d919-4362-9883-96255a60200e", "evidence": "Similar to slide 1, this slide presents a clear attention-grabbing headline, followed by a brief description of the therapeutic strategy, and supporting evidence from a lead compound, which aligns with the AIDA model's structure.", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-16 23:58:06.514195+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 36, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [ { "matchId": "f670b55e-16ee-457c-b7b5-2f716b631c80", "evidence": "The top row uses chevron shapes to indicate a logical progression from genetics to clinical relevance.", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 12:57:48.15+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 36, "frameworkName": "process" } ], "arcBeats": [], "loops": [], "locked": true }, { "page": 37, "type": "appendix", "function": "appendix", "rawType": "appendix", "block": null, "metadata": { "slideType": "appendix", "slideTypeCanon": { "name": "Appendix", "slug": "appendix", "status": "active", "canonId": "019de52d-0762-71f8-b564-89ab863301cc", "version": 1, "description": null }, "function": "appendix", "functionCanon": { "name": "Appendix", "slug": "appendix", "status": "active", "canonId": "019de52d-138d-750b-83c3-49b4bc7a7a38", "version": 1, "description": null }, "density": "sparse", "densityScore": 6, "componentCount": 2, "textChars": 55, "nDataPoints": 0, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 12:57:50.451+00", "seconds": 5.313, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/37", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-37", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.45, "w": 0.3, "x": 0.6, "y": 0.26 }, "kind": "image", "text": null, "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Illustration", "slug": "illustration", "status": "active", "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615", "version": 1, "description": null }, "framework": null }, "subkind": "illustration", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:50.451+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "fed4589a-6913-44e2-bd4b-11b2b0a1a885", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.5, "x": 0.11, "y": 0.63 }, "kind": "title", "text": "APPENDIX: Building Value Through Legacy Oncology Assets", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 12:57:50.451+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "283aeea2-bec8-47c0-b457-7685e70c2feb", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 38, "type": "evidence", "title": "The slide details a specific business development milestone involving a licensing deal and potential revenue streams.", "function": "show_traction", "rawType": "traction", "block": null, "metadata": { "slideType": "traction", "slideTypeCanon": { "name": "Traction", "slug": "traction", "status": "active", "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542", "version": 1, "description": null }, "function": "show_traction", "functionCanon": { "name": "Show traction", "slug": "show_traction", "status": "active", "canonId": "019de52d-16a8-756a-9b38-a7d35420561d", "version": 1, "description": null }, "density": "dense", "densityScore": 57, "componentCount": 4, "textChars": 1023, "nDataPoints": 1, "notes": "The slide details a specific business development milestone involving a licensing deal and potential revenue streams.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 15:32:09.736+00", "seconds": 3.529, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de072-7781-7512-96cc-a2b05ce755c7/38", "deck": "/decks/019de072-7781-7512-96cc-a2b05ce755c7", "deckAnchor": "/decks/019de072-7781-7512-96cc-a2b05ce755c7#slide-38", "deckJson": "/decks/019de072-7781-7512-96cc-a2b05ce755c7.json" }, "components": [ { "bbox": { "h": 0.25, "w": 0.35, "x": 0.05, "y": 0.0034500000000000004 }, "kind": "image", "text": "carina biotech", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 15:32:09.736+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5396ee78-3dfe-46ce-ac1e-c48321ce02da", "parentComponentId": null }, { "bbox": { "h": 0.65, "w": 0.51, "x": 0.46, "y": 0.00135 }, "kind": "list", "text": "Exclusive Agreement to license Bionomics' BNC101 oncology drug candidate to Carina Biotech for the development of Chimeric Antigen Receptor T cell (CAR-T) therapy, which harnesses the body's immune system to fight cancer.\nBionomics is eligible to receive up to A$118 million in clinical & development milestones plus royalty payments if Carina fully develops and markets the new therapy. In the event that Carina sub-licenses the CAR-T treatment, Bionomics is eligible to share in the sub-licensing revenues in early clinical development and receive a substantial double-digit portion of the revenues in later stages of clinical development.\nIn September 2021, Carina announced that it plans to initiate a clinical trial of BNC101 CAR-T therapy for the treatment of advanced colorectal (bowel) cancer in late 2022\nBionomics retains BNC101 for other types of therapies", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 15:32:09.736+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5ade88f5-510c-4bfc-bde8-c938147aa754", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.39, "x": 0.03, "y": 0.00175 }, "kind": "title", "text": "Exclusive BNC101 Oncology License Agreement for the Development of CAR-T Therapeutics", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 15:32:09.736+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "1f68418e-07b3-4c8d-8705-227bec2efa3b", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.62, "x": 0.09, "y": 0.03 }, "kind": "title", "text": "Legacy Oncology Asset Monetization to Drive Value: BNC101", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 15:32:09.736+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "aa772124-8bc7-460f-a771-c8038d7a0103", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "Before-After-Bridge", "slug": "before-after-bridge", "status": "active", "bestFor": null, "canonId": "019dd956-8604-7188-883f-42370288ad05", "version": 1, "bodyDocId": null, "description": "Narrative structure: Paint the before, show the after, explain the bridge", "familyLabel": null, "categoryName": "Block", "categorySlug": "block" }, "agent": "Storyteller", "layer": "slide", "agents": [ "Storyteller" ], "matchId": "8a923516-f8ab-4e4f-9ab4-e73f2d61e488", "evidence": "The slide presents a clear 'before' state (legacy oncology assets) and an 'after' state (monetization of these assets through a licensing agreement), which aligns with the before-after-bridge tool.", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.8, "extraction": { "at": "2026-07-16 23:58:06.623546+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 38, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [], "arcBeats": [], "loops": [], "locked": true } ], "arcBeats": [ { "from": 15, "to": 15, "label": "Problem", "description": "The problem statement is presented on page 15, highlighting the disease burden of Post-Traumatic Stress Disorder." }, { "from": 5, "to": 6, "label": "Solution", "description": "The solution is presented on pages 5-6, introducing Bionomics' differentiated approach through the α7 Nicotinic Acetylcholine Receptor." }, { "from": 8, "to": 8, "label": "Market Size", "description": "Market sizing is presented on page 8, targeting a large segment of the anxiety market." }, { "from": 9, "to": 10, "label": "Traction", "description": "Traction is presented on pages 9-10, showcasing BNC210's efficacy in reducing panic symptoms and demonstrating acute anxiolytic activity." }, { "from": 12, "to": 12, "label": "Why Now", "description": "The why now section is presented on page 12, highlighting BNC210's rapid onset of action and its potential in Social Anxiety Disorder." } ], "loops": [ { "from": 3, "to": 3, "label": "Golden Circle", "description": "Why Bionomics?" }, { "from": 15, "to": 15, "label": "Cost Of Inaction", "description": "What is the cost of not treating PTSD effectively?" }, { "from": 9, "to": 10, "label": "Quick Win Big Bet", "description": "Can BNC210 provide a quick win in treating anxiety disorders?" } ] }